|
rno03010
|
Ribosome
|
52/344
|
422/7214
|
0.0000000
|
0.0000000
|
ENSRNOG00000037897/ENSRNOG00000005116/ENSRNOG00000019578/ENSRNOG00000011104/ENSRNOG00000026260/ENSRNOG00000028021/ENSRNOG00000008555/ENSRNOG00000020354/ENSRNOG00000042886/ENSRNOG00000008516/ENSRNOG00000061438/ENSRNOG00000002789/ENSRNOG00000052141/ENSRNOG00000004107/ENSRNOG00000024603/ENSRNOG00000033473/ENSRNOG00000017127/ENSRNOG00000046349/ENSRNOG00000033916/ENSRNOG00000050473/ENSRNOG00000032803/ENSRNOG00000060449/ENSRNOG00000020674/ENSRNOG00000008140/ENSRNOG00000019106/ENSRNOG00000019949/ENSRNOG00000054489/ENSRNOG00000020595/ENSRNOG00000027039/ENSRNOG00000031560/ENSRNOG00000031022/ENSRNOG00000001611/ENSRNOG00000025936/ENSRNOG00000049097/ENSRNOG00000025179/ENSRNOG00000036695/ENSRNOG00000018647/ENSRNOG00000011138/ENSRNOG00000000490/ENSRNOG00000014214/ENSRNOG00000032635/ENSRNOG00000049442/ENSRNOG00000019007/ENSRNOG00000033152/ENSRNOG00000022934/ENSRNOG00000019974/ENSRNOG00000031641/ENSRNOG00000032835/ENSRNOG00000015335/ENSRNOG00000048456/ENSRNOG00000047365/ENSRNOG00000014272
|
Rps19/AABR07054332.1/Rps16/LOC100363800/Rpl11/LOC684988/Rps20/Mrpl23/Rps28/LOC688684/AC106663.5/AABR07039648.1/Rps10/Rpl23/Rps15/Rpl36/Rpl28/LOC100360604/LOC100363012/Rps27l/LOC100361811/AC115322.4/Rpl27/Rpl15/Rps17/Mrps12/AABR07042821.1/Rps11/Mrpl22/LOC681195/LOC100912182/Rpl24/Rpl6/Rpl7a/LOC100361061/Mrpl12/Mrpl20/Rpl29/Rps10/Rpl27a/LOC100360117/Rps28/Rpl14/LOC100360679/Rps2-ps6/Uba52/Rpl35a/Rpl39/Rpl13/Rpl8/LOC687780/Rpl35
|
rno:108348115/rno:83789/rno:140655/rno:81768/rno:362631/rno:684988/rno:100362684/rno:64360/rno:691531/rno:28298/rno:81765/rno:83789/rno:100363439/rno:29282/rno:29285/rno:58927/rno:64638/rno:79449/rno:81775/rno:681429/rno:79449/rno:81775/rno:64306/rno:245981/rno:100365810/rno:292758/rno:58927/rno:81774/rno:287302/rno:79449/rno:108348287/rno:64307/rno:117042/rno:296596/rno:317646/rno:303746/rno:680747/rno:29283/rno:100363439/rno:293418/rno:100360117/rno:691531/rno:65043/rno:100360679/rno:83789/rno:64156/rno:108349682/rno:103692785/rno:81765/rno:100360117/rno:687780/rno:296709
|
52
|
|
rno05012
|
Parkinson disease
|
27/344
|
282/7214
|
0.0003939
|
0.0545540
|
ENSRNOG00000020602/ENSRNOG00000016952/ENSRNOG00000030871/ENSRNOG00000006939/ENSRNOG00000018289/ENSRNOG00000020299/ENSRNOG00000010420/ENSRNOG00000001170/ENSRNOG00000048320/ENSRNOG00000059061/ENSRNOG00000022448/ENSRNOG00000011572/ENSRNOG00000024539/ENSRNOG00000012457/ENSRNOG00000037580/ENSRNOG00000055984/ENSRNOG00000018816/ENSRNOG00000010038/ENSRNOG00000007946/ENSRNOG00000021042/ENSRNOG00000001339/ENSRNOG00000014625/ENSRNOG00000019974/ENSRNOG00000029339/ENSRNOG00000020876/ENSRNOG00000018371/ENSRNOG00000015320
|
Ndufa13/LOC686442/Calm2/Ndufa7/Park7/Klc2/Shfm1/Cox6a1/Ndufa11/Uqcr10/Htra2/Klc1/Ndufb6/Cyc1/Psmd8/Adrm1/Cox5a/Psmc5/Bcl2l1/Psmd4/Psmd9/Atp5d/Uba52/LOC100363268/Bax/Tubb6/Atp5g2
|
rno:100911483/rno:690848/rno:24244/rno:299643/rno:117287/rno:309159/rno:680532/rno:25282/rno:301123/rno:685322/rno:297376/rno:171041/rno:297990/rno:300047/rno:292766/rno:65138/rno:252934/rno:81827/rno:24888/rno:83499/rno:161475/rno:245965/rno:64156/rno:100363268/rno:24887/rno:307351/rno:171082
|
27
|
|
rno03040
|
Spliceosome
|
19/344
|
174/7214
|
0.0005924
|
0.0547005
|
ENSRNOG00000021215/ENSRNOG00000020763/ENSRNOG00000019349/ENSRNOG00000017708/ENSRNOG00000019572/ENSRNOG00000020475/ENSRNOG00000013533/ENSRNOG00000001501/ENSRNOG00000016507/ENSRNOG00000019552/ENSRNOG00000014619/ENSRNOG00000009960/ENSRNOG00000001163/ENSRNOG00000030374/ENSRNOG00000000104/ENSRNOG00000000493/ENSRNOG00000020412/ENSRNOG00000010007/ENSRNOG00000015914
|
Rbm8a/Snrnp70/Sf3a2/AABR07073038.1/Lsm4/Sart1/Acin1/Snrpa/LOC100360635/Lsm7/Dhx38/Puf60/Srsf9/LOC100360750/Thoc3/Snrpc/Sf3b2/Srsf4/U2af2
|
rno:295284/rno:361574/rno:299620/rno:500242/rno:290647/rno:29678/rno:305884/rno:292729/rno:687679/rno:362829/rno:292007/rno:84401/rno:288701/rno:100360750/rno:290519/rno:361808/rno:293671/rno:362612/rno:308335
|
19
|
|
rno04510
|
Focal adhesion
|
20/344
|
204/7214
|
0.0016634
|
0.1151898
|
ENSRNOG00000016367/ENSRNOG00000019253/novel.1951/ENSRNOG00000017354/ENSRNOG00000020246/ENSRNOG00000020918/ENSRNOG00000053691/ENSRNOG00000058645/ENSRNOG00000020433/ENSRNOG00000017645/ENSRNOG00000001149/ENSRNOG00000028629/ENSRNOG00000007281/ENSRNOG00000023972/ENSRNOG00000009495/ENSRNOG00000053828/ENSRNOG00000018708/ENSRNOG00000016611/ENSRNOG00000004276/ENSRNOG00000057451
|
Vasp/Bcar1/-/Zyx/Myl9/Ccnd1/Lama5/Tnc/Actn4/Mylpf/Pxn/Akt1/Flnc/Col4a2/Src/Ppp1r12c/Ppp1ca/Hras/Itga3/Itga5
|
rno:361517/rno:25414/rno:170851/rno:114636/rno:296313/rno:58919/rno:140433/rno:116640/rno:63836/rno:24584/rno:360820/rno:24185/rno:362332/rno:306628/rno:83805/rno:499076/rno:24668/rno:293621/rno:360606/rno:315346
|
20
|
|
rno05016
|
Huntington disease
|
28/344
|
340/7214
|
0.0031364
|
0.1737539
|
ENSRNOG00000020602/ENSRNOG00000016952/ENSRNOG00000002115/ENSRNOG00000017506/ENSRNOG00000006939/ENSRNOG00000020299/ENSRNOG00000010420/ENSRNOG00000001170/ENSRNOG00000048320/ENSRNOG00000059061/ENSRNOG00000023521/ENSRNOG00000011572/ENSRNOG00000024539/ENSRNOG00000012457/ENSRNOG00000037580/ENSRNOG00000055984/ENSRNOG00000018816/ENSRNOG00000010038/ENSRNOG00000021042/ENSRNOG00000001339/ENSRNOG00000014625/novel.508/ENSRNOG00000029339/ENSRNOG00000020876/ENSRNOG00000015720/ENSRNOG00000014635/ENSRNOG00000018371/ENSRNOG00000015320
|
Ndufa13/LOC686442/Sod1/Cltb/Ndufa7/Klc2/Shfm1/Cox6a1/Ndufa11/Uqcr10/Map3k10/Klc1/Ndufb6/Cyc1/Psmd8/Adrm1/Cox5a/Psmc5/Psmd4/Psmd9/Atp5d/-/LOC100363268/Bax/Polr2c/Clta/Tubb6/Atp5g2
|
rno:100911483/rno:690848/rno:24786/rno:116561/rno:299643/rno:309159/rno:680532/rno:25282/rno:301123/rno:685322/rno:308463/rno:171041/rno:297990/rno:300047/rno:292766/rno:65138/rno:252934/rno:81827/rno:83499/rno:161475/rno:245965/rno:117252/rno:100363268/rno:24887/rno:361365/rno:83800/rno:307351/rno:171082
|
28
|
|
rno05220
|
Chronic myeloid leukemia
|
10/344
|
85/7214
|
0.0068925
|
0.3182027
|
novel.1951/ENSRNOG00000013090/ENSRNOG00000020918/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000001704/ENSRNOG00000020876/ENSRNOG00000009867/ENSRNOG00000016611
|
-/Gadd45g/Ccnd1/Tgfb1/Akt1/Bcl2l1/Runx1/Bax/Tgfb3/Hras
|
rno:170851/rno:291005/rno:58919/rno:59086/rno:24185/rno:24888/rno:50662/rno:24887/rno:25717/rno:293621
|
10
|
|
rno00190
|
Oxidative phosphorylation
|
15/344
|
159/7214
|
0.0086660
|
0.3429256
|
ENSRNOG00000020602/ENSRNOG00000007392/ENSRNOG00000016952/ENSRNOG00000000064/ENSRNOG00000006939/ENSRNOG00000001170/ENSRNOG00000048320/ENSRNOG00000059061/ENSRNOG00000024539/ENSRNOG00000012457/ENSRNOG00000018816/ENSRNOG00000014625/ENSRNOG00000029339/ENSRNOG00000015320/ENSRNOG00000008163
|
Ndufa13/Atp6v1f/LOC686442/Atp5i/Ndufa7/Cox6a1/Ndufa11/Uqcr10/Ndufb6/Cyc1/Cox5a/Atp5d/LOC100363268/Atp5g2/Atp6v1g1
|
rno:100911483/rno:116664/rno:690848/rno:140608/rno:299643/rno:25282/rno:301123/rno:685322/rno:297990/rno:300047/rno:252934/rno:245965/rno:100363268/rno:171082/rno:298103
|
15
|
|
rno05216
|
Thyroid cancer
|
6/344
|
40/7214
|
0.0109410
|
0.3788332
|
novel.1951/ENSRNOG00000013090/ENSRNOG00000020918/ENSRNOG00000000464/ENSRNOG00000020876/ENSRNOG00000016611
|
-/Gadd45g/Ccnd1/Rxrb/Bax/Hras
|
rno:170851/rno:291005/rno:58919/rno:361801/rno:24887/rno:293621
|
6
|
|
rno04810
|
Regulation of actin cytoskeleton
|
18/344
|
215/7214
|
0.0140235
|
0.4316109
|
ENSRNOG00000049236/ENSRNOG00000019253/novel.1951/ENSRNOG00000020660/ENSRNOG00000003975/ENSRNOG00000020246/ENSRNOG00000018524/ENSRNOG00000020433/ENSRNOG00000017645/ENSRNOG00000001149/ENSRNOG00000008994/ENSRNOG00000009495/ENSRNOG00000018878/ENSRNOG00000053828/ENSRNOG00000018708/ENSRNOG00000016611/ENSRNOG00000004276/ENSRNOG00000057451
|
LOC100911597/Bcar1/-/Cfl1/Pfn1/Myl9/Ezr/Actn4/Mylpf/Pxn/Arpc4/Src/Ssh3/Ppp1r12c/Ppp1ca/Hras/Itga3/Itga5
|
rno:25745/rno:25414/rno:170851/rno:29271/rno:64303/rno:296313/rno:54319/rno:63836/rno:24584/rno:360820/rno:297518/rno:83805/rno:365396/rno:499076/rno:24668/rno:293621/rno:360606/rno:315346
|
18
|
|
rno05222
|
Small cell lung cancer
|
10/344
|
96/7214
|
0.0156886
|
0.4322860
|
ENSRNOG00000013090/ENSRNOG00000010436/ENSRNOG00000020918/ENSRNOG00000053691/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000023972/ENSRNOG00000000464/ENSRNOG00000020876/ENSRNOG00000004276
|
Gadd45g/Zbtb17/Ccnd1/Lama5/Akt1/Bcl2l1/Col4a2/Rxrb/Bax/Itga3
|
rno:291005/rno:313666/rno:58919/rno:140433/rno:24185/rno:24888/rno:306628/rno:361801/rno:24887/rno:360606
|
10
|
|
rno03410
|
Base excision repair
|
6/344
|
44/7214
|
0.0171666
|
0.4322860
|
ENSRNOG00000019915/ENSRNOG00000020531/ENSRNOG00000016748/ENSRNOG00000014098/ENSRNOG00000009663/ENSRNOG00000003084
|
Xrcc1/Fen1/Poll/Pold2/Apex1/Parp1
|
rno:84495/rno:84490/rno:361767/rno:289758/rno:79116/rno:25591
|
6
|
|
rno05010
|
Alzheimer disease
|
29/344
|
408/7214
|
0.0193662
|
0.4470354
|
ENSRNOG00000020602/novel.1951/ENSRNOG00000024429/ENSRNOG00000016952/ENSRNOG00000021962/ENSRNOG00000030871/ENSRNOG00000006939/ENSRNOG00000020299/ENSRNOG00000030963/ENSRNOG00000010420/ENSRNOG00000001170/ENSRNOG00000048320/ENSRNOG00000059061/ENSRNOG00000011572/ENSRNOG00000024539/ENSRNOG00000012457/ENSRNOG00000037580/ENSRNOG00000055984/ENSRNOG00000018816/ENSRNOG00000010038/ENSRNOG00000028629/ENSRNOG00000021042/ENSRNOG00000001339/ENSRNOG00000014625/ENSRNOG00000018020/ENSRNOG00000029339/ENSRNOG00000018371/ENSRNOG00000015320/ENSRNOG00000016611
|
Ndufa13/-/Peg12/LOC686442/Fzd2/Calm2/Ndufa7/Klc2/LOC685186/Shfm1/Cox6a1/Ndufa11/Uqcr10/Klc1/Ndufb6/Cyc1/Psmd8/Adrm1/Cox5a/Psmc5/Akt1/Psmd4/Psmd9/Atp5d/Apbb1/LOC100363268/Tubb6/Atp5g2/Hras
|
rno:100911483/rno:170851/rno:308692/rno:690848/rno:64512/rno:24244/rno:299643/rno:309159/rno:24383/rno:680532/rno:25282/rno:301123/rno:685322/rno:171041/rno:297990/rno:300047/rno:292766/rno:65138/rno:252934/rno:81827/rno:24185/rno:83499/rno:161475/rno:245965/rno:29722/rno:100363268/rno:307351/rno:171082/rno:293621
|
29
|
|
rno05205
|
Proteoglycans in cancer
|
17/344
|
210/7214
|
0.0224668
|
0.4787162
|
novel.1951/ENSRNOG00000021962/ENSRNOG00000020918/novel.1507/ENSRNOG00000018524/ENSRNOG00000021437/ENSRNOG00000049437/ENSRNOG00000020652/ENSRNOG00000001149/ENSRNOG00000028629/ENSRNOG00000007281/ENSRNOG00000009495/ENSRNOG00000053828/ENSRNOG00000011101/ENSRNOG00000018708/ENSRNOG00000016611/ENSRNOG00000057451
|
-/Fzd2/Ccnd1/-/Ezr/AABR07073181.1/Gpc1/Tgfb1/Pxn/Akt1/Flnc/Src/Ppp1r12c/Twist1/Ppp1ca/Hras/Itga5
|
rno:170851/rno:64512/rno:58919/rno:313641/rno:54319/rno:313641/rno:58920/rno:59086/rno:360820/rno:24185/rno:362332/rno:83805/rno:499076/rno:85489/rno:24668/rno:293621/rno:315346
|
17
|
|
rno04932
|
Non-alcoholic fatty liver disease (NAFLD)
|
14/344
|
168/7214
|
0.0293215
|
0.5543834
|
ENSRNOG00000020602/ENSRNOG00000016952/ENSRNOG00000006939/ENSRNOG00000001170/ENSRNOG00000048320/ENSRNOG00000059061/ENSRNOG00000001142/ENSRNOG00000020652/ENSRNOG00000024539/ENSRNOG00000012457/ENSRNOG00000018816/ENSRNOG00000028629/ENSRNOG00000029339/ENSRNOG00000020876
|
Ndufa13/LOC686442/Ndufa7/Cox6a1/Ndufa11/Uqcr10/Prkab1/Tgfb1/Ndufb6/Cyc1/Cox5a/Akt1/LOC100363268/Bax
|
rno:100911483/rno:690848/rno:299643/rno:25282/rno:301123/rno:685322/rno:83803/rno:59086/rno:297990/rno:300047/rno:252934/rno:24185/rno:100363268/rno:24887
|
14
|
|
rno04068
|
FoxO signaling pathway
|
12/344
|
137/7214
|
0.0300208
|
0.5543834
|
novel.1951/ENSRNOG00000013090/ENSRNOG00000014287/ENSRNOG00000020918/ENSRNOG00000018815/ENSRNOG00000018536/ENSRNOG00000001142/ENSRNOG00000014205/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000009867/ENSRNOG00000016611
|
-/Gadd45g/Stk11/Ccnd1/Plk1/Pck2/Prkab1/Klf2/Tgfb1/Akt1/Tgfb3/Hras
|
rno:170851/rno:291005/rno:314621/rno:58919/rno:25515/rno:361042/rno:83803/rno:306330/rno:59086/rno:24185/rno:25717/rno:293621
|
12
|
|
rno05212
|
Pancreatic cancer
|
8/344
|
81/7214
|
0.0384115
|
0.6493856
|
novel.1951/ENSRNOG00000013090/ENSRNOG00000020918/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000020876/ENSRNOG00000009867
|
-/Gadd45g/Ccnd1/Tgfb1/Akt1/Bcl2l1/Bax/Tgfb3
|
rno:170851/rno:291005/rno:58919/rno:59086/rno:24185/rno:24888/rno:24887/rno:25717
|
8
|
|
rno04910
|
Insulin signaling pathway
|
12/344
|
145/7214
|
0.0436349
|
0.6493856
|
ENSRNOG00000012582/novel.1951/ENSRNOG00000030871/ENSRNOG00000000826/ENSRNOG00000010574/ENSRNOG00000046891/ENSRNOG00000018536/ENSRNOG00000028733/ENSRNOG00000001142/ENSRNOG00000028629/ENSRNOG00000018708/ENSRNOG00000016611
|
Eif4ebp1/-/Calm2/Flot1/Ptpn1/Hk1/Pck2/Prkar1b/Prkab1/Akt1/Ppp1ca/Hras
|
rno:116636/rno:170851/rno:24244/rno:64665/rno:24697/rno:25058/rno:361042/rno:25521/rno:83803/rno:24185/rno:24668/rno:293621
|
12
|
|
rno05223
|
Non-small cell lung cancer
|
7/344
|
69/7214
|
0.0451866
|
0.6493856
|
novel.1951/ENSRNOG00000013090/ENSRNOG00000020918/ENSRNOG00000028629/ENSRNOG00000000464/ENSRNOG00000020876/ENSRNOG00000016611
|
-/Gadd45g/Ccnd1/Akt1/Rxrb/Bax/Hras
|
rno:170851/rno:291005/rno:58919/rno:24185/rno:361801/rno:24887/rno:293621
|
7
|
|
rno03050
|
Proteasome
|
6/344
|
56/7214
|
0.0492460
|
0.6493856
|
ENSRNOG00000010420/ENSRNOG00000037580/ENSRNOG00000055984/ENSRNOG00000010038/ENSRNOG00000021042/ENSRNOG00000001339
|
Shfm1/Psmd8/Adrm1/Psmc5/Psmd4/Psmd9
|
rno:680532/rno:292766/rno:65138/rno:81827/rno:83499/rno:161475
|
6
|
|
rno00340
|
Histidine metabolism
|
3/344
|
18/7214
|
0.0515296
|
0.6493856
|
ENSRNOG00000002331/ENSRNOG00000015591/ENSRNOG00000014645
|
Aldh3a1/Cndp2/Aldh7a1
|
rno:25375/rno:291394/rno:291450
|
3
|
|
rno05166
|
Human T-cell leukemia virus 1 infection
|
17/344
|
235/7214
|
0.0560996
|
0.6493856
|
novel.1951/ENSRNOG00000018232/ENSRNOG00000020918/ENSRNOG00000019311/ENSRNOG00000058388/ENSRNOG00000020652/ENSRNOG00000019264/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000001884/ENSRNOG00000022421/ENSRNOG00000020876/ENSRNOG00000001265/ENSRNOG00000051499/ENSRNOG00000009867/ENSRNOG00000049785/ENSRNOG00000016611
|
-/Srf/Ccnd1/Nfkb2/Zfp36/Tgfb1/Ltbr/Akt1/Bcl2l1/RGD1565297/Crtc1/Bax/Mad1l1/Tcf3/Tgfb3/Ranbp3/Hras
|
rno:170851/rno:501099/rno:58919/rno:309452/rno:79426/rno:59086/rno:297604/rno:24185/rno:24888/rno:360739/rno:684527/rno:24887/rno:680006/rno:171046/rno:25717/rno:501281/rno:293621
|
17
|
|
rno04216
|
Ferroptosis
|
6/344
|
58/7214
|
0.0567832
|
0.6493856
|
ENSRNOG00000020843/ENSRNOG00000017708/ENSRNOG00000036511/ENSRNOG00000025443/ENSRNOG00000031506/ENSRNOG00000004662
|
Ftl1/AABR07073038.1/AABR07063638.1/Map1lc3a/LOC100360087/RGD1560687
|
rno:100360087/rno:500242/rno:100360087/rno:362245/rno:100360087/rno:100360087
|
6
|
|
rno05132
|
Salmonella infection
|
18/344
|
253/7214
|
0.0574140
|
0.6493856
|
ENSRNOG00000054140/ENSRNOG00000049236/novel.1951/ENSRNOG00000014992/ENSRNOG00000003975/ENSRNOG00000020299/ENSRNOG00000030963/ENSRNOG00000020246/ENSRNOG00000018568/ENSRNOG00000011572/ENSRNOG00000058011/ENSRNOG00000008994/ENSRNOG00000008921/ENSRNOG00000028629/ENSRNOG00000007728/ENSRNOG00000007281/ENSRNOG00000020876/ENSRNOG00000016611
|
LOC102551071/LOC100911597/-/M6pr/Pfn1/Klc2/LOC685186/Myl9/Rab5c/Klc1/AABR07018244.1/Arpc4/Dynll2/Akt1/Gsdmd/Flnc/Bax/Hras
|
rno:685867/rno:25745/rno:170851/rno:100909548/rno:64303/rno:309159/rno:24383/rno:296313/rno:287709/rno:171041/rno:56611/rno:297518/rno:140734/rno:24185/rno:315084/rno:362332/rno:24887/rno:293621
|
18
|
|
rno00410
|
beta-Alanine metabolism
|
4/344
|
31/7214
|
0.0579437
|
0.6493856
|
ENSRNOG00000002331/ENSRNOG00000015591/ENSRNOG00000014522/ENSRNOG00000014645
|
Aldh3a1/Cndp2/Mlycd/Aldh7a1
|
rno:25375/rno:291394/rno:85239/rno:291450
|
4
|
|
rno04530
|
Tight junction
|
13/344
|
172/7214
|
0.0667299
|
0.6493856
|
ENSRNOG00000054140/ENSRNOG00000049236/ENSRNOG00000016367/ENSRNOG00000014287/ENSRNOG00000020246/ENSRNOG00000020918/ENSRNOG00000018524/ENSRNOG00000001142/ENSRNOG00000018980/ENSRNOG00000020433/ENSRNOG00000001704/ENSRNOG00000019181/ENSRNOG00000009495
|
LOC102551071/LOC100911597/Vasp/Stk11/Myl9/Ccnd1/Ezr/Prkab1/Tjap1/Actn4/Runx1/Synpo/Src
|
rno:685867/rno:25745/rno:361517/rno:314621/rno:296313/rno:58919/rno:54319/rno:83803/rno:316233/rno:63836/rno:50662/rno:60324/rno:83805
|
13
|
|
rno05214
|
Glioma
|
7/344
|
76/7214
|
0.0693570
|
0.6493856
|
novel.1951/ENSRNOG00000013090/ENSRNOG00000030871/ENSRNOG00000020918/ENSRNOG00000028629/ENSRNOG00000020876/ENSRNOG00000016611
|
-/Gadd45g/Calm2/Ccnd1/Akt1/Bax/Hras
|
rno:170851/rno:291005/rno:24244/rno:58919/rno:24185/rno:24887/rno:293621
|
7
|
|
rno05410
|
Hypertrophic cardiomyopathy (HCM)
|
8/344
|
92/7214
|
0.0713686
|
0.6493856
|
ENSRNOG00000001142/ENSRNOG00000058882/ENSRNOG00000003998/ENSRNOG00000020652/ENSRNOG00000033734/ENSRNOG00000009867/ENSRNOG00000004276/ENSRNOG00000057451
|
Prkab1/Emd/Sgca/Tgfb1/Tnnt2/Tgfb3/Itga3/Itga5
|
rno:83803/rno:25437/rno:303468/rno:59086/rno:24837/rno:25717/rno:360606/rno:315346
|
8
|
|
rno04210
|
Apoptosis
|
11/344
|
141/7214
|
0.0730774
|
0.6493856
|
novel.1951/ENSRNOG00000013090/ENSRNOG00000016571/ENSRNOG00000022448/ENSRNOG00000013774/ENSRNOG00000025742/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000003084/ENSRNOG00000020876/ENSRNOG00000016611
|
-/Gadd45g/Ngf/Htra2/Lmnb1/Lmnb2/Akt1/Bcl2l1/Parp1/Bax/Hras
|
rno:170851/rno:291005/rno:310738/rno:297376/rno:116685/rno:299625/rno:24185/rno:24888/rno:25591/rno:24887/rno:293621
|
11
|
|
rno04921
|
Oxytocin signaling pathway
|
11/344
|
141/7214
|
0.0730774
|
0.6493856
|
ENSRNOG00000054140/novel.1951/ENSRNOG00000030871/ENSRNOG00000020246/ENSRNOG00000020918/ENSRNOG00000001142/ENSRNOG00000009495/ENSRNOG00000016448/ENSRNOG00000053828/ENSRNOG00000018708/ENSRNOG00000016611
|
LOC102551071/-/Calm2/Myl9/Ccnd1/Prkab1/Src/Eef2k/Ppp1r12c/Ppp1ca/Hras
|
rno:685867/rno:170851/rno:24244/rno:296313/rno:58919/rno:83803/rno:83805/rno:25435/rno:499076/rno:24668/rno:293621
|
11
|
|
rno05226
|
Gastric cancer
|
11/344
|
141/7214
|
0.0730774
|
0.6493856
|
novel.1951/ENSRNOG00000024429/ENSRNOG00000013090/ENSRNOG00000021962/ENSRNOG00000020918/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000000464/ENSRNOG00000020876/ENSRNOG00000009867/ENSRNOG00000016611
|
-/Peg12/Gadd45g/Fzd2/Ccnd1/Tgfb1/Akt1/Rxrb/Bax/Tgfb3/Hras
|
rno:170851/rno:308692/rno:291005/rno:64512/rno:58919/rno:59086/rno:24185/rno:361801/rno:24887/rno:25717/rno:293621
|
11
|
|
rno05225
|
Hepatocellular carcinoma
|
13/344
|
175/7214
|
0.0743093
|
0.6493856
|
novel.1951/ENSRNOG00000024429/ENSRNOG00000013090/ENSRNOG00000021962/ENSRNOG00000020918/ENSRNOG00000007743/ENSRNOG00000020652/ENSRNOG00000012772/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000020876/ENSRNOG00000009867/ENSRNOG00000016611
|
-/Peg12/Gadd45g/Fzd2/Ccnd1/Mgst1/Tgfb1/Nqo1/Akt1/Bcl2l1/Bax/Tgfb3/Hras
|
rno:170851/rno:308692/rno:291005/rno:64512/rno:58919/rno:171341/rno:59086/rno:24314/rno:24185/rno:24888/rno:24887/rno:25717/rno:293621
|
13
|
|
rno05210
|
Colorectal cancer
|
8/344
|
93/7214
|
0.0750193
|
0.6493856
|
novel.1951/ENSRNOG00000013090/ENSRNOG00000020918/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000020876/ENSRNOG00000009867/ENSRNOG00000016611
|
-/Gadd45g/Ccnd1/Tgfb1/Akt1/Bax/Tgfb3/Hras
|
rno:170851/rno:291005/rno:58919/rno:59086/rno:24185/rno:24887/rno:25717/rno:293621
|
8
|
|
rno05213
|
Endometrial cancer
|
6/344
|
65/7214
|
0.0883307
|
0.7379676
|
novel.1951/ENSRNOG00000013090/ENSRNOG00000020918/ENSRNOG00000028629/ENSRNOG00000020876/ENSRNOG00000016611
|
-/Gadd45g/Ccnd1/Akt1/Bax/Hras
|
rno:170851/rno:291005/rno:58919/rno:24185/rno:24887/rno:293621
|
6
|
|
rno05100
|
Bacterial invasion of epithelial cells
|
7/344
|
81/7214
|
0.0905809
|
0.7379676
|
ENSRNOG00000019253/ENSRNOG00000017506/ENSRNOG00000001149/ENSRNOG00000008994/ENSRNOG00000009495/ENSRNOG00000014635/ENSRNOG00000057451
|
Bcar1/Cltb/Pxn/Arpc4/Src/Clta/Itga5
|
rno:25414/rno:116561/rno:360820/rno:297518/rno:83805/rno:83800/rno:315346
|
7
|
|
rno05211
|
Renal cell carcinoma
|
7/344
|
83/7214
|
0.0999888
|
0.7588628
|
ENSRNOG00000058914/novel.1951/ENSRNOG00000020652/ENSRNOG00000020947/ENSRNOG00000028629/ENSRNOG00000009867/ENSRNOG00000016611
|
Rbx1/-/Tgfb1/Egln2/Akt1/Tgfb3/Hras
|
rno:300084/rno:170851/rno:59086/rno:308457/rno:24185/rno:25717/rno:293621
|
7
|
|
rno03015
|
mRNA surveillance pathway
|
8/344
|
100/7214
|
0.1036690
|
0.7588628
|
ENSRNOG00000021215/ENSRNOG00000031387/ENSRNOG00000017397/ENSRNOG00000010732/ENSRNOG00000013533/ENSRNOG00000058130/ENSRNOG00000049270/ENSRNOG00000018708
|
Rbm8a/Dazap1/Upf3a/RGD1561590/Acin1/Wibg/Ppp2r3b/Ppp1ca
|
rno:295284/rno:362836/rno:361176/rno:290284/rno:305884/rno:366790/rno:682033/rno:24668
|
8
|
|
rno04933
|
AGE-RAGE signaling pathway in diabetic complications
|
8/344
|
100/7214
|
0.1036690
|
0.7588628
|
ENSRNOG00000020918/ENSRNOG00000003033/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000023972/ENSRNOG00000020876/ENSRNOG00000009867/ENSRNOG00000016611
|
Ccnd1/Plcd3/Tgfb1/Akt1/Col4a2/Bax/Tgfb3/Hras
|
rno:58919/rno:287745/rno:59086/rno:24185/rno:306628/rno:24887/rno:25717/rno:293621
|
8
|
|
rno05218
|
Melanoma
|
6/344
|
68/7214
|
0.1042756
|
0.7588628
|
novel.1951/ENSRNOG00000013090/ENSRNOG00000020918/ENSRNOG00000028629/ENSRNOG00000020876/ENSRNOG00000016611
|
-/Gadd45g/Ccnd1/Akt1/Bax/Hras
|
rno:170851/rno:291005/rno:58919/rno:24185/rno:24887/rno:293621
|
6
|
|
rno03450
|
Non-homologous end-joining
|
2/344
|
12/7214
|
0.1091874
|
0.7588628
|
ENSRNOG00000020531/ENSRNOG00000016748
|
Fen1/Poll
|
rno:84490/rno:361767
|
2
|
|
rno05219
|
Bladder cancer
|
4/344
|
39/7214
|
0.1132260
|
0.7588628
|
novel.1951/ENSRNOG00000020918/ENSRNOG00000009495/ENSRNOG00000016611
|
-/Ccnd1/Src/Hras
|
rno:170851/rno:58919/rno:83805/rno:293621
|
4
|
|
rno01521
|
EGFR tyrosine kinase inhibitor resistance
|
7/344
|
86/7214
|
0.1150622
|
0.7588628
|
ENSRNOG00000012582/novel.1951/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000009495/ENSRNOG00000020876/ENSRNOG00000016611
|
Eif4ebp1/-/Akt1/Bcl2l1/Src/Bax/Hras
|
rno:116636/rno:170851/rno:24185/rno:24888/rno:83805/rno:24887/rno:293621
|
7
|
|
rno04512
|
ECM-receptor interaction
|
7/344
|
86/7214
|
0.1150622
|
0.7588628
|
ENSRNOG00000053691/novel.1507/ENSRNOG00000021437/ENSRNOG00000058645/ENSRNOG00000023972/ENSRNOG00000004276/ENSRNOG00000057451
|
Lama5/-/AABR07073181.1/Tnc/Col4a2/Itga3/Itga5
|
rno:140433/rno:313641/rno:313641/rno:116640/rno:306628/rno:360606/rno:315346
|
7
|
|
rno05221
|
Acute myeloid leukemia
|
6/344
|
71/7214
|
0.1216136
|
0.7834177
|
ENSRNOG00000012582/novel.1951/ENSRNOG00000020918/ENSRNOG00000028629/ENSRNOG00000001704/ENSRNOG00000016611
|
Eif4ebp1/-/Ccnd1/Akt1/Runx1/Hras
|
rno:116636/rno:170851/rno:58919/rno:24185/rno:50662/rno:293621
|
6
|
|
rno00740
|
Riboflavin metabolism
|
2/344
|
13/7214
|
0.1251274
|
0.7877339
|
ENSRNOG00000020642/ENSRNOG00000024410
|
Flad1/Blvrb
|
rno:751787/rno:292737
|
2
|
|
rno04144
|
Endocytosis
|
18/344
|
283/7214
|
0.1288677
|
0.7932521
|
ENSRNOG00000017506/ENSRNOG00000018568/ENSRNOG00000012764/ENSRNOG00000034071/ENSRNOG00000019435/ENSRNOG00000043503/ENSRNOG00000009946/ENSRNOG00000049683/ENSRNOG00000014615/ENSRNOG00000043150/ENSRNOG00000008994/ENSRNOG00000056009/ENSRNOG00000009495/ENSRNOG00000017172/ENSRNOG00000022014/ENSRNOG00000014635/ENSRNOG00000015753/ENSRNOG00000016611
|
Cltb/Rab5c/Agap3/Chmp4bl1/Psd/Ehd1/Ldlr/Sh3gl1/Grk6/Arfgap1/Arpc4/Rab11fip5/Src/Mvb12b/Rab35/Clta/Epn1/Hras
|
rno:116561/rno:287709/rno:362300/rno:679886/rno:171381/rno:293692/rno:300438/rno:81922/rno:59076/rno:246310/rno:297518/rno:312502/rno:83805/rno:362118/rno:288700/rno:83800/rno:117277/rno:293621
|
18
|
|
rno04670
|
Leukocyte transendothelial migration
|
8/344
|
106/7214
|
0.1324431
|
0.7975380
|
ENSRNOG00000016367/ENSRNOG00000019253/ENSRNOG00000020246/ENSRNOG00000006604/ENSRNOG00000018524/ENSRNOG00000020433/ENSRNOG00000017645/ENSRNOG00000001149
|
Vasp/Bcar1/Myl9/Thy1/Ezr/Actn4/Mylpf/Pxn
|
rno:361517/rno:25414/rno:296313/rno:24832/rno:54319/rno:63836/rno:24584/rno:360820
|
8
|
|
rno04141
|
Protein processing in endoplasmic reticulum
|
12/344
|
177/7214
|
0.1382901
|
0.8150292
|
ENSRNOG00000058914/ENSRNOG00000008604/ENSRNOG00000025570/ENSRNOG00000048509/ENSRNOG00000020938/ENSRNOG00000001803/ENSRNOG00000016161/ENSRNOG00000053172/ENSRNOG00000019798/ENSRNOG00000001348/ENSRNOG00000009409/ENSRNOG00000020876
|
Rbx1/Nsfl1c/Os9/Ubxn6/Ppp1r15a/Dnajb11/Lman2/Ssr4/Stub1/Erp29/Fbxo2/Bax
|
rno:300084/rno:83809/rno:362891/rno:363332/rno:171071/rno:360734/rno:290994/rno:29435/rno:287155/rno:117030/rno:85273/rno:24887
|
12
|
|
rno00620
|
Pyruvate metabolism
|
4/344
|
43/7214
|
0.1471611
|
0.8423233
|
ENSRNOG00000026519/ENSRNOG00000018536/ENSRNOG00000014645/ENSRNOG00000012794
|
AABR07044711.1/Pck2/Aldh7a1/Grhpr
|
rno:100364062/rno:361042/rno:291450/rno:680021
|
4
|
|
rno04370
|
VEGF signaling pathway
|
5/344
|
59/7214
|
0.1490030
|
0.8423233
|
novel.1951/ENSRNOG00000001149/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000016611
|
-/Pxn/Akt1/Src/Hras
|
rno:170851/rno:360820/rno:24185/rno:83805/rno:293621
|
5
|
|
rno05230
|
Central carbon metabolism in cancer
|
6/344
|
76/7214
|
0.1534145
|
0.8434060
|
novel.1951/ENSRNOG00000026519/ENSRNOG00000046891/ENSRNOG00000006393/ENSRNOG00000028629/ENSRNOG00000016611
|
-/AABR07044711.1/Hk1/Sirt6/Akt1/Hras
|
rno:170851/rno:100364062/rno:25058/rno:299638/rno:24185/rno:293621
|
6
|
|
rno04110
|
Cell cycle
|
9/344
|
128/7214
|
0.1567795
|
0.8434060
|
ENSRNOG00000058914/ENSRNOG00000013090/ENSRNOG00000010436/ENSRNOG00000020918/ENSRNOG00000018815/ENSRNOG00000020652/ENSRNOG00000003657/ENSRNOG00000001265/ENSRNOG00000009867
|
Rbx1/Gadd45g/Zbtb17/Ccnd1/Plk1/Tgfb1/Pkmyt1/Mad1l1/Tgfb3
|
rno:300084/rno:291005/rno:313666/rno:58919/rno:25515/rno:59086/rno:287101/rno:680006/rno:25717
|
9
|
|
rno00630
|
Glyoxylate and dicarboxylate metabolism
|
3/344
|
29/7214
|
0.1583289
|
0.8434060
|
ENSRNOG00000008106/ENSRNOG00000012794/ENSRNOG00000049560
|
Shmt2/Grhpr/Glul
|
rno:299857/rno:680021/rno:24957
|
3
|
|
rno05414
|
Dilated cardiomyopathy (DCM)
|
7/344
|
95/7214
|
0.1667947
|
0.8567049
|
ENSRNOG00000058882/ENSRNOG00000003998/ENSRNOG00000020652/ENSRNOG00000033734/ENSRNOG00000009867/ENSRNOG00000004276/ENSRNOG00000057451
|
Emd/Sgca/Tgfb1/Tnnt2/Tgfb3/Itga3/Itga5
|
rno:25437/rno:303468/rno:59086/rno:24837/rno:25717/rno:360606/rno:315346
|
7
|
|
rno04152
|
AMPK signaling pathway
|
9/344
|
130/7214
|
0.1672257
|
0.8567049
|
ENSRNOG00000012582/ENSRNOG00000014287/ENSRNOG00000020918/ENSRNOG00000018536/ENSRNOG00000014522/ENSRNOG00000001142/ENSRNOG00000049270/ENSRNOG00000028629/ENSRNOG00000016448
|
Eif4ebp1/Stk11/Ccnd1/Pck2/Mlycd/Prkab1/Ppp2r3b/Akt1/Eef2k
|
rno:116636/rno:314621/rno:58919/rno:361042/rno:85239/rno:83803/rno:682033/rno:24185/rno:25435
|
9
|
|
rno05020
|
Prion diseases
|
3/344
|
30/7214
|
0.1701039
|
0.8567049
|
novel.1951/ENSRNOG00000002115/ENSRNOG00000020876
|
-/Sod1/Bax
|
rno:170851/rno:24786/rno:24887
|
3
|
|
rno00052
|
Galactose metabolism
|
3/344
|
31/7214
|
0.1821210
|
0.8965348
|
ENSRNOG00000046891/ENSRNOG00000009712/ENSRNOG00000006359
|
Hk1/Gale/Galk1
|
rno:25058/rno:114860/rno:287835
|
3
|
|
rno00520
|
Amino sugar and nucleotide sugar metabolism
|
4/344
|
47/7214
|
0.1844855
|
0.8965348
|
ENSRNOG00000005358/ENSRNOG00000046891/ENSRNOG00000009712/ENSRNOG00000006359
|
Pmm1/Hk1/Gale/Galk1
|
rno:300089/rno:25058/rno:114860/rno:287835
|
4
|
|
rno04714
|
Thermogenesis
|
16/344
|
264/7214
|
0.1924841
|
0.9192773
|
ENSRNOG00000020602/ENSRNOG00000016952/ENSRNOG00000000064/ENSRNOG00000006939/ENSRNOG00000001170/ENSRNOG00000048320/ENSRNOG00000059061/ENSRNOG00000006393/ENSRNOG00000001142/ENSRNOG00000024539/ENSRNOG00000012457/ENSRNOG00000018816/ENSRNOG00000014625/ENSRNOG00000029339/ENSRNOG00000015320/ENSRNOG00000016611
|
Ndufa13/LOC686442/Atp5i/Ndufa7/Cox6a1/Ndufa11/Uqcr10/Sirt6/Prkab1/Ndufb6/Cyc1/Cox5a/Atp5d/LOC100363268/Atp5g2/Hras
|
rno:100911483/rno:690848/rno:140608/rno:299643/rno:25282/rno:301123/rno:685322/rno:299638/rno:83803/rno:297990/rno:300047/rno:252934/rno:245965/rno:100363268/rno:171082/rno:293621
|
16
|
|
rno04920
|
Adipocytokine signaling pathway
|
5/344
|
66/7214
|
0.2055691
|
0.9520476
|
ENSRNOG00000014287/ENSRNOG00000018536/ENSRNOG00000001142/ENSRNOG00000028629/ENSRNOG00000000464
|
Stk11/Pck2/Prkab1/Akt1/Rxrb
|
rno:314621/rno:361042/rno:83803/rno:24185/rno:361801
|
5
|
|
rno05017
|
Spinocerebellar ataxia
|
9/344
|
137/7214
|
0.2062197
|
0.9520476
|
ENSRNOG00000010420/ENSRNOG00000026994/ENSRNOG00000037580/ENSRNOG00000055984/ENSRNOG00000011306/ENSRNOG00000010038/ENSRNOG00000028629/ENSRNOG00000021042/ENSRNOG00000001339
|
Shfm1/Afg3l1/Psmd8/Adrm1/Myod1/Psmc5/Akt1/Psmd4/Psmd9
|
rno:680532/rno:361436/rno:292766/rno:65138/rno:337868/rno:81827/rno:24185/rno:83499/rno:161475
|
9
|
|
rno00532
|
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate
|
2/344
|
18/7214
|
0.2108635
|
0.9575275
|
ENSRNOG00000008885/ENSRNOG00000010466
|
Chst11/Chpf2
|
rno:314694/rno:296733
|
2
|
|
rno04371
|
Apelin signaling pathway
|
9/344
|
140/7214
|
0.2239866
|
0.9780276
|
novel.1951/ENSRNOG00000058039/ENSRNOG00000030871/ENSRNOG00000020918/ENSRNOG00000001142/ENSRNOG00000014205/ENSRNOG00000028629/ENSRNOG00000001409/ENSRNOG00000016611
|
-/Acta2/Calm2/Ccnd1/Prkab1/Klf2/Akt1/Gnb2/Hras
|
rno:170851/rno:81633/rno:24244/rno:58919/rno:83803/rno:306330/rno:24185/rno:81667/rno:293621
|
9
|
|
rno05224
|
Breast cancer
|
9/344
|
140/7214
|
0.2239866
|
0.9780276
|
novel.1951/ENSRNOG00000024429/ENSRNOG00000013090/ENSRNOG00000021962/ENSRNOG00000020918/ENSRNOG00000019311/ENSRNOG00000028629/ENSRNOG00000020876/ENSRNOG00000016611
|
-/Peg12/Gadd45g/Fzd2/Ccnd1/Nfkb2/Akt1/Bax/Hras
|
rno:170851/rno:308692/rno:291005/rno:64512/rno:58919/rno:309452/rno:24185/rno:24887/rno:293621
|
9
|
|
rno04270
|
Vascular smooth muscle contraction
|
8/344
|
122/7214
|
0.2259703
|
0.9780276
|
ENSRNOG00000054140/ENSRNOG00000049236/novel.1951/ENSRNOG00000058039/ENSRNOG00000030871/ENSRNOG00000020246/ENSRNOG00000053828/ENSRNOG00000018708
|
LOC102551071/LOC100911597/-/Acta2/Calm2/Myl9/Ppp1r12c/Ppp1ca
|
rno:685867/rno:25745/rno:170851/rno:81633/rno:24244/rno:296313/rno:499076/rno:24668
|
8
|
|
rno00980
|
Metabolism of xenobiotics by cytochrome P450
|
4/344
|
52/7214
|
0.2348411
|
0.9836969
|
ENSRNOG00000002331/ENSRNOG00000019500/ENSRNOG00000007743/ENSRNOG00000001701
|
Aldh3a1/Cyp1a1/Mgst1/Cbr3
|
rno:25375/rno:24296/rno:171341/rno:304078
|
4
|
|
rno04917
|
Prolactin signaling pathway
|
5/344
|
70/7214
|
0.2406565
|
0.9836969
|
novel.1951/ENSRNOG00000020918/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000016611
|
-/Ccnd1/Akt1/Src/Hras
|
rno:170851/rno:58919/rno:24185/rno:83805/rno:293621
|
5
|
|
rno04260
|
Cardiac muscle contraction
|
6/344
|
88/7214
|
0.2421009
|
0.9836969
|
ENSRNOG00000016952/ENSRNOG00000001170/ENSRNOG00000059061/ENSRNOG00000012457/ENSRNOG00000018816/ENSRNOG00000033734
|
LOC686442/Cox6a1/Uqcr10/Cyc1/Cox5a/Tnnt2
|
rno:690848/rno:25282/rno:685322/rno:300047/rno:252934/rno:24837
|
6
|
|
rno04215
|
Apoptosis - multiple species
|
3/344
|
36/7214
|
0.2450405
|
0.9836969
|
ENSRNOG00000022448/ENSRNOG00000007946/ENSRNOG00000020876
|
Htra2/Bcl2l1/Bax
|
rno:297376/rno:24888/rno:24887
|
3
|
|
rno05146
|
Amoebiasis
|
6/344
|
89/7214
|
0.2501139
|
0.9836969
|
ENSRNOG00000018568/ENSRNOG00000053691/ENSRNOG00000020433/ENSRNOG00000020652/ENSRNOG00000023972/ENSRNOG00000009867
|
Rab5c/Lama5/Actn4/Tgfb1/Col4a2/Tgfb3
|
rno:287709/rno:140433/rno:63836/rno:59086/rno:306628/rno:25717
|
6
|
|
rno00330
|
Arginine and proline metabolism
|
4/344
|
54/7214
|
0.2558468
|
0.9836969
|
ENSRNOG00000015591/ENSRNOG00000015267/ENSRNOG00000017118/ENSRNOG00000014645
|
Cndp2/Aldh18a1/P4ha3/Aldh7a1
|
rno:291394/rno:361755/rno:361612/rno:291450
|
4
|
|
rno04211
|
Longevity regulating pathway
|
6/344
|
90/7214
|
0.2582010
|
0.9836969
|
ENSRNOG00000012582/ENSRNOG00000014287/ENSRNOG00000001142/ENSRNOG00000028629/ENSRNOG00000020876/ENSRNOG00000016611
|
Eif4ebp1/Stk11/Prkab1/Akt1/Bax/Hras
|
rno:116636/rno:314621/rno:83803/rno:24185/rno:24887/rno:293621
|
6
|
|
rno00983
|
Drug metabolism - other enzymes
|
5/344
|
72/7214
|
0.2587782
|
0.9836969
|
ENSRNOG00000048561/ENSRNOG00000002693/ENSRNOG00000003917/ENSRNOG00000007743/ENSRNOG00000007081
|
Hprt1/Nme1/Uck2/Mgst1/Xdh
|
rno:103689983/rno:191575/rno:304944/rno:171341/rno:497811
|
5
|
|
rno04926
|
Relaxin signaling pathway
|
8/344
|
127/7214
|
0.2592414
|
0.9836969
|
novel.1951/ENSRNOG00000058039/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000023972/ENSRNOG00000009495/ENSRNOG00000001409/ENSRNOG00000016611
|
-/Acta2/Tgfb1/Akt1/Col4a2/Src/Gnb2/Hras
|
rno:170851/rno:81633/rno:59086/rno:24185/rno:306628/rno:83805/rno:81667/rno:293621
|
8
|
|
rno05203
|
Viral carcinogenesis
|
13/344
|
223/7214
|
0.2660068
|
0.9902347
|
ENSRNOG00000026519/ENSRNOG00000018232/ENSRNOG00000020918/ENSRNOG00000019311/ENSRNOG00000020433/ENSRNOG00000055597/ENSRNOG00000019264/ENSRNOG00000001149/ENSRNOG00000001884/ENSRNOG00000009495/ENSRNOG00000020876/ENSRNOG00000001265/ENSRNOG00000016611
|
AABR07044711.1/Srf/Ccnd1/Nfkb2/Actn4/Hdac7/Ltbr/Pxn/RGD1565297/Src/Bax/Mad1l1/Hras
|
rno:100364062/rno:501099/rno:58919/rno:309452/rno:63836/rno:84582/rno:297604/rno:360820/rno:360739/rno:83805/rno:24887/rno:680006/rno:293621
|
13
|
|
rno04218
|
Cellular senescence
|
11/344
|
186/7214
|
0.2735126
|
0.9902347
|
ENSRNOG00000012582/novel.1951/ENSRNOG00000013090/ENSRNOG00000030871/ENSRNOG00000050108/ENSRNOG00000020918/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000009867/ENSRNOG00000018708/ENSRNOG00000016611
|
Eif4ebp1/-/Gadd45g/Calm2/LOC100911319/Ccnd1/Tgfb1/Akt1/Tgfb3/Ppp1ca/Hras
|
rno:116636/rno:170851/rno:291005/rno:24244/rno:100911319/rno:58919/rno:59086/rno:24185/rno:25717/rno:24668/rno:293621
|
11
|
|
rno05014
|
Amyotrophic lateral sclerosis (ALS)
|
4/344
|
56/7214
|
0.2772133
|
0.9902347
|
ENSRNOG00000018556/ENSRNOG00000002115/ENSRNOG00000007946/ENSRNOG00000020876
|
Tomm40/Sod1/Bcl2l1/Bax
|
rno:308416/rno:24786/rno:24888/rno:24887
|
4
|
|
rno03013
|
RNA transport
|
11/344
|
189/7214
|
0.2908884
|
0.9902347
|
ENSRNOG00000012582/ENSRNOG00000021215/ENSRNOG00000017397/ENSRNOG00000020619/ENSRNOG00000010732/ENSRNOG00000030704/ENSRNOG00000013533/ENSRNOG00000058130/ENSRNOG00000001039/ENSRNOG00000025310/ENSRNOG00000000104
|
Eif4ebp1/Rbm8a/Upf3a/Eif3g/RGD1561590/LOC100911693/Acin1/Wibg/Eif2b1/Pop7/Thoc3
|
rno:116636/rno:295284/rno:361176/rno:298700/rno:290284/rno:287986/rno:305884/rno:366790/rno:64514/rno:288564/rno:290519
|
11
|
|
rno00010
|
Glycolysis / Gluconeogenesis
|
6/344
|
94/7214
|
0.2911962
|
0.9902347
|
ENSRNOG00000002331/ENSRNOG00000030963/ENSRNOG00000026519/ENSRNOG00000046891/ENSRNOG00000018536/ENSRNOG00000014645
|
Aldh3a1/LOC685186/AABR07044711.1/Hk1/Pck2/Aldh7a1
|
rno:25375/rno:24383/rno:100364062/rno:25058/rno:361042/rno:291450
|
6
|
|
rno04380
|
Osteoclast differentiation
|
7/344
|
113/7214
|
0.2933134
|
0.9902347
|
ENSRNOG00000042838/novel.1951/ENSRNOG00000016866/ENSRNOG00000019568/ENSRNOG00000019311/ENSRNOG00000020652/ENSRNOG00000028629
|
Junb/-/Fhl2/Jund/Nfkb2/Tgfb1/Akt1
|
rno:24517/rno:170851/rno:63839/rno:24518/rno:309452/rno:59086/rno:24185
|
7
|
|
rno03440
|
Homologous recombination
|
3/344
|
40/7214
|
0.2974949
|
0.9902347
|
ENSRNOG00000010420/ENSRNOG00000020617/ENSRNOG00000014098
|
Shfm1/Mus81/Pold2
|
rno:680532/rno:293678/rno:289758
|
3
|
|
rno05163
|
Human cytomegalovirus infection
|
13/344
|
229/7214
|
0.2976082
|
0.9902347
|
ENSRNOG00000012582/ENSRNOG00000019253/novel.1951/ENSRNOG00000030871/ENSRNOG00000020918/ENSRNOG00000001149/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000020876/ENSRNOG00000004094/ENSRNOG00000001409/ENSRNOG00000016611/ENSRNOG00000029500
|
Eif4ebp1/Bcar1/-/Calm2/Ccnd1/Pxn/Akt1/Src/Bax/Ptger1/Gnb2/Hras/Tapbp
|
rno:116636/rno:25414/rno:170851/rno:24244/rno:58919/rno:360820/rno:24185/rno:83805/rno:24887/rno:25637/rno:81667/rno:293621/rno:25217
|
13
|
|
rno04962
|
Vasopressin-regulated water reabsorption
|
3/344
|
41/7214
|
0.3107396
|
0.9902347
|
ENSRNOG00000018568/ENSRNOG00000019302/ENSRNOG00000008921
|
Rab5c/Stx4/Dynll2
|
rno:287709/rno:81803/rno:140734
|
3
|
|
rno04913
|
Ovarian steroidogenesis
|
3/344
|
42/7214
|
0.3240016
|
0.9902347
|
ENSRNOG00000019500/ENSRNOG00000009946/ENSRNOG00000053460
|
Cyp1a1/Ldlr/Acot3
|
rno:24296/rno:300438/rno:314304
|
3
|
|
rno04973
|
Carbohydrate digestion and absorption
|
3/344
|
42/7214
|
0.3240016
|
0.9902347
|
ENSRNOG00000046891/ENSRNOG00000028629/ENSRNOG00000017693
|
Hk1/Akt1/Slc2a5
|
rno:25058/rno:24185/rno:65197
|
3
|
|
rno05170
|
Human immunodeficiency virus 1 infection
|
13/344
|
234/7214
|
0.3247306
|
0.9902347
|
ENSRNOG00000058914/novel.1951/ENSRNOG00000011663/ENSRNOG00000020660/ENSRNOG00000030871/ENSRNOG00000001149/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000020876/ENSRNOG00000001409/ENSRNOG00000016611/ENSRNOG00000001415/ENSRNOG00000029500
|
Rbx1/-/Rnf7/Cfl1/Calm2/Pxn/Akt1/Bcl2l1/Bax/Gnb2/Hras/Ap1s1/Tapbp
|
rno:300084/rno:170851/rno:300948/rno:29271/rno:24244/rno:360820/rno:24185/rno:24888/rno:24887/rno:81667/rno:293621/rno:360785/rno:25217
|
13
|
|
rno01522
|
Endocrine resistance
|
6/344
|
98/7214
|
0.3249976
|
0.9902347
|
novel.1951/ENSRNOG00000020918/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000020876/ENSRNOG00000016611
|
-/Ccnd1/Akt1/Src/Bax/Hras
|
rno:170851/rno:58919/rno:24185/rno:83805/rno:24887/rno:293621
|
6
|
|
rno04064
|
NF-kappa B signaling pathway
|
6/344
|
99/7214
|
0.3335385
|
0.9902347
|
ENSRNOG00000013090/ENSRNOG00000019311/ENSRNOG00000019264/ENSRNOG00000007946/ENSRNOG00000003084/ENSRNOG00000020230
|
Gadd45g/Nfkb2/Ltbr/Bcl2l1/Parp1/Pias4
|
rno:291005/rno:309452/rno:297604/rno:24888/rno:25591/rno:362827
|
6
|
|
rno00260
|
Glycine, serine and threonine metabolism
|
3/344
|
43/7214
|
0.3372647
|
0.9902347
|
ENSRNOG00000008106/ENSRNOG00000014645/ENSRNOG00000012794
|
Shmt2/Aldh7a1/Grhpr
|
rno:299857/rno:291450/rno:680021
|
3
|
|
rno05161
|
Hepatitis B
|
9/344
|
158/7214
|
0.3403160
|
0.9902347
|
novel.1951/novel.1507/ENSRNOG00000021437/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000020876/ENSRNOG00000009867/ENSRNOG00000016611
|
-/-/AABR07073181.1/Tgfb1/Akt1/Src/Bax/Tgfb3/Hras
|
rno:170851/rno:313641/rno:313641/rno:59086/rno:24185/rno:83805/rno:24887/rno:25717/rno:293621
|
9
|
|
rno04015
|
Rap1 signaling pathway
|
11/344
|
199/7214
|
0.3507688
|
0.9902347
|
ENSRNOG00000016367/ENSRNOG00000019253/novel.1951/ENSRNOG00000016571/ENSRNOG00000030871/ENSRNOG00000003975/ENSRNOG00000020703/ENSRNOG00000028629/ENSRNOG00000020573/ENSRNOG00000009495/ENSRNOG00000016611
|
Vasp/Bcar1/-/Ngf/Calm2/Pfn1/Sipa1l3/Akt1/Efna1/Src/Hras
|
rno:361517/rno:25414/rno:170851/rno:310738/rno:24244/rno:64303/rno:361442/rno:24185/rno:94268/rno:83805/rno:293621
|
11
|
|
rno04520
|
Adherens junction
|
5/344
|
82/7214
|
0.3529873
|
0.9902347
|
ENSRNOG00000010574/ENSRNOG00000020433/ENSRNOG00000009594/ENSRNOG00000009495/ENSRNOG00000018730
|
Ptpn1/Actn4/Snai1/Src/Pvrl2
|
rno:24697/rno:63836/rno:116490/rno:83805/rno:308417
|
5
|
|
rno04720
|
Long-term potentiation
|
4/344
|
63/7214
|
0.3536331
|
0.9902347
|
novel.1951/ENSRNOG00000030871/ENSRNOG00000018708/ENSRNOG00000016611
|
-/Calm2/Ppp1ca/Hras
|
rno:170851/rno:24244/rno:24668/rno:293621
|
4
|
|
rno04966
|
Collecting duct acid secretion
|
2/344
|
26/7214
|
0.3539075
|
0.9902347
|
ENSRNOG00000007392/ENSRNOG00000008163
|
Atp6v1f/Atp6v1g1
|
rno:116664/rno:298103
|
2
|
|
rno04978
|
Mineral absorption
|
4/344
|
64/7214
|
0.3646278
|
0.9902347
|
ENSRNOG00000020843/ENSRNOG00000036511/ENSRNOG00000031506/ENSRNOG00000004662
|
Ftl1/AABR07063638.1/LOC100360087/RGD1560687
|
rno:100360087/rno:100360087/rno:100360087/rno:100360087
|
4
|
|
rno05202
|
Transcriptional misregulation in cancer
|
10/344
|
183/7214
|
0.3751099
|
0.9902347
|
ENSRNOG00000057347/ENSRNOG00000013090/ENSRNOG00000010436/ENSRNOG00000023360/ENSRNOG00000051372/ENSRNOG00000007946/ENSRNOG00000001704/ENSRNOG00000000464/ENSRNOG00000020876/ENSRNOG00000051499
|
Cebpb/Gadd45g/Zbtb17/Fus/Mycn/Bcl2l1/Runx1/Rxrb/Bax/Tcf3
|
rno:24253/rno:291005/rno:313666/rno:317385/rno:298894/rno:24888/rno:50662/rno:361801/rno:24887/rno:171046
|
10
|
|
rno04114
|
Oocyte meiosis
|
7/344
|
124/7214
|
0.3791428
|
0.9902347
|
ENSRNOG00000058914/novel.1951/ENSRNOG00000030871/ENSRNOG00000018815/ENSRNOG00000003657/ENSRNOG00000001265/ENSRNOG00000018708
|
Rbx1/-/Calm2/Plk1/Pkmyt1/Mad1l1/Ppp1ca
|
rno:300084/rno:170851/rno:24244/rno:25515/rno:287101/rno:680006/rno:24668
|
7
|
|
rno05165
|
Human papillomavirus infection
|
18/344
|
345/7214
|
0.3805314
|
0.9902347
|
ENSRNOG00000012582/novel.1951/ENSRNOG00000007392/ENSRNOG00000021962/ENSRNOG00000001250/ENSRNOG00000026519/ENSRNOG00000020918/ENSRNOG00000053691/ENSRNOG00000058645/ENSRNOG00000049270/ENSRNOG00000001149/ENSRNOG00000028629/ENSRNOG00000023972/ENSRNOG00000020876/ENSRNOG00000016611/ENSRNOG00000004276/ENSRNOG00000057451/ENSRNOG00000008163
|
Eif4ebp1/-/Atp6v1f/Fzd2/Lfng/AABR07044711.1/Ccnd1/Lama5/Tnc/Ppp2r3b/Pxn/Akt1/Col4a2/Bax/Hras/Itga3/Itga5/Atp6v1g1
|
rno:116636/rno:170851/rno:116664/rno:64512/rno:170905/rno:100364062/rno:58919/rno:140433/rno:116640/rno:682033/rno:360820/rno:24185/rno:306628/rno:24887/rno:293621/rno:360606/rno:315346/rno:298103
|
18
|
|
rno03008
|
Ribosome biogenesis in eukaryotes
|
5/344
|
85/7214
|
0.3817844
|
0.9902347
|
ENSRNOG00000055562/ENSRNOG00000010409/ENSRNOG00000017916/ENSRNOG00000025310/ENSRNOG00000049497
|
Dkc1/Nol6/Rexo1/Pop7/Eif6
|
rno:170944/rno:313167/rno:314630/rno:288564/rno:305506
|
5
|
|
rno04922
|
Glucagon signaling pathway
|
6/344
|
105/7214
|
0.3851939
|
0.9902347
|
ENSRNOG00000030871/ENSRNOG00000026519/ENSRNOG00000018536/ENSRNOG00000001142/ENSRNOG00000019813/ENSRNOG00000028629
|
Calm2/AABR07044711.1/Pck2/Prkab1/Ppp4c/Akt1
|
rno:24244/rno:100364062/rno:361042/rno:83803/rno:171366/rno:24185
|
6
|
|
rno05169
|
Epstein-Barr virus infection
|
12/344
|
225/7214
|
0.3869842
|
0.9902347
|
ENSRNOG00000013090/ENSRNOG00000010420/ENSRNOG00000020918/ENSRNOG00000019311/ENSRNOG00000037580/ENSRNOG00000001004/ENSRNOG00000055984/ENSRNOG00000010038/ENSRNOG00000028629/ENSRNOG00000021042/ENSRNOG00000020876/ENSRNOG00000029500
|
Gadd45g/Shfm1/Ccnd1/Nfkb2/Psmd8/Ncor2/Adrm1/Psmc5/Akt1/Psmd4/Bax/Tapbp
|
rno:291005/rno:680532/rno:58919/rno:309452/rno:292766/rno:360801/rno:65138/rno:81827/rno:24185/rno:83499/rno:24887/rno:25217
|
12
|
|
rno04722
|
Neurotrophin signaling pathway
|
7/344
|
125/7214
|
0.3870560
|
0.9902347
|
novel.1951/ENSRNOG00000016571/ENSRNOG00000030871/ENSRNOG00000049181/ENSRNOG00000028629/ENSRNOG00000020876/ENSRNOG00000016611
|
-/Ngf/Calm2/Sh2b1/Akt1/Bax/Hras
|
rno:170851/rno:310738/rno:24244/rno:89817/rno:24185/rno:24887/rno:293621
|
7
|
|
rno04919
|
Thyroid hormone signaling pathway
|
7/344
|
125/7214
|
0.3870560
|
0.9902347
|
novel.1951/ENSRNOG00000020918/ENSRNOG00000003033/ENSRNOG00000028629/ENSRNOG00000000464/ENSRNOG00000009495/ENSRNOG00000016611
|
-/Ccnd1/Plcd3/Akt1/Rxrb/Src/Hras
|
rno:170851/rno:58919/rno:287745/rno:24185/rno:361801/rno:83805/rno:293621
|
7
|
|
rno05418
|
Fluid shear stress and atherosclerosis
|
8/344
|
145/7214
|
0.3879659
|
0.9902347
|
ENSRNOG00000030871/ENSRNOG00000007743/ENSRNOG00000049437/ENSRNOG00000014205/ENSRNOG00000012772/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000020230
|
Calm2/Mgst1/Gpc1/Klf2/Nqo1/Akt1/Src/Pias4
|
rno:24244/rno:171341/rno:58920/rno:306330/rno:24314/rno:24185/rno:83805/rno:362827
|
8
|
|
rno00510
|
N-Glycan biosynthesis
|
3/344
|
47/7214
|
0.3900285
|
0.9902347
|
ENSRNOG00000004591/ENSRNOG00000049110/ENSRNOG00000031208
|
Alg12/Dpm2/Mgat1
|
rno:315212/rno:29640/rno:81519
|
3
|
|
rno00970
|
Aminoacyl-tRNA biosynthesis
|
3/344
|
48/7214
|
0.4030794
|
0.9902347
|
ENSRNOG00000000867/ENSRNOG00000025808/ENSRNOG00000028105
|
Vars/Aars2/Hars
|
rno:25009/rno:301254/rno:307492
|
3
|
|
rno01230
|
Biosynthesis of amino acids
|
6/344
|
108/7214
|
0.4110891
|
0.9902347
|
ENSRNOG00000030963/ENSRNOG00000026519/ENSRNOG00000015267/ENSRNOG00000020956/ENSRNOG00000008106/ENSRNOG00000049560
|
LOC685186/AABR07044711.1/Aldh18a1/Bcat2/Shmt2/Glul
|
rno:24383/rno:100364062/rno:361755/rno:64203/rno:299857/rno:24957
|
6
|
|
rno00280
|
Valine, leucine and isoleucine degradation
|
3/344
|
49/7214
|
0.4160497
|
0.9902347
|
ENSRNOG00000020956/ENSRNOG00000014645/ENSRNOG00000000967
|
Bcat2/Aldh7a1/Aacs
|
rno:64203/rno:291450/rno:65984
|
3
|
|
rno04066
|
HIF-1 signaling pathway
|
8/344
|
149/7214
|
0.4173829
|
0.9902347
|
ENSRNOG00000012582/ENSRNOG00000058914/novel.1951/ENSRNOG00000030963/ENSRNOG00000046891/ENSRNOG00000019264/ENSRNOG00000020947/ENSRNOG00000028629
|
Eif4ebp1/Rbx1/-/LOC685186/Hk1/Ltbr/Egln2/Akt1
|
rno:116636/rno:300084/rno:170851/rno:24383/rno:25058/rno:297604/rno:308457/rno:24185
|
8
|
|
rno04012
|
ErbB signaling pathway
|
5/344
|
89/7214
|
0.4200868
|
0.9902347
|
ENSRNOG00000012582/novel.1951/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000016611
|
Eif4ebp1/-/Akt1/Src/Hras
|
rno:116636/rno:170851/rno:24185/rno:83805/rno:293621
|
5
|
|
rno00062
|
Fatty acid elongation
|
2/344
|
30/7214
|
0.4225345
|
0.9902347
|
ENSRNOG00000021808/ENSRNOG00000053460
|
Tecr/Acot3
|
rno:191576/rno:314304
|
2
|
|
rno03020
|
RNA polymerase
|
2/344
|
30/7214
|
0.4225345
|
0.9902347
|
ENSRNOG00000019079/ENSRNOG00000015720
|
Polr1c/Polr2c
|
rno:301246/rno:361365
|
2
|
|
rno05145
|
Toxoplasmosis
|
6/344
|
110/7214
|
0.4283020
|
0.9902347
|
ENSRNOG00000053691/ENSRNOG00000009946/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000009867
|
Lama5/Ldlr/Tgfb1/Akt1/Bcl2l1/Tgfb3
|
rno:140433/rno:300438/rno:59086/rno:24185/rno:24888/rno:25717
|
6
|
|
rno04912
|
GnRH signaling pathway
|
5/344
|
90/7214
|
0.4296094
|
0.9902347
|
novel.1951/ENSRNOG00000030871/ENSRNOG00000010947/ENSRNOG00000009495/ENSRNOG00000016611
|
-/Calm2/Mmp14/Src/Hras
|
rno:170851/rno:24244/rno:81707/rno:83805/rno:293621
|
5
|
|
rno04721
|
Synaptic vesicle cycle
|
4/344
|
70/7214
|
0.4301491
|
0.9902347
|
ENSRNOG00000007392/ENSRNOG00000017506/ENSRNOG00000014635/ENSRNOG00000008163
|
Atp6v1f/Cltb/Clta/Atp6v1g1
|
rno:116664/rno:116561/rno:83800/rno:298103
|
4
|
|
rno04062
|
Chemokine signaling pathway
|
8/344
|
151/7214
|
0.4320748
|
0.9902347
|
ENSRNOG00000019253/novel.1951/ENSRNOG00000014615/ENSRNOG00000001149/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000001409/ENSRNOG00000016611
|
Bcar1/-/Grk6/Pxn/Akt1/Src/Gnb2/Hras
|
rno:25414/rno:170851/rno:59076/rno:360820/rno:24185/rno:83805/rno:81667/rno:293621
|
8
|
|
rno00020
|
Citrate cycle (TCA cycle)
|
2/344
|
31/7214
|
0.4391148
|
0.9902347
|
ENSRNOG00000018536/ENSRNOG00000005587
|
Pck2/Suclg1
|
rno:361042/rno:114597
|
2
|
|
rno01040
|
Biosynthesis of unsaturated fatty acids
|
2/344
|
31/7214
|
0.4391148
|
0.9902347
|
ENSRNOG00000021808/ENSRNOG00000053460
|
Tecr/Acot3
|
rno:191576/rno:314304
|
2
|
|
rno04710
|
Circadian rhythm
|
2/344
|
31/7214
|
0.4391148
|
0.9902347
|
ENSRNOG00000058914/ENSRNOG00000001142
|
Rbx1/Prkab1
|
rno:300084/rno:83803
|
2
|
|
rno04217
|
Necroptosis
|
9/344
|
173/7214
|
0.4434134
|
0.9902347
|
ENSRNOG00000020843/ENSRNOG00000038375/ENSRNOG00000036511/ENSRNOG00000034071/ENSRNOG00000031506/ENSRNOG00000049560/ENSRNOG00000003084/ENSRNOG00000020876/ENSRNOG00000004662
|
Ftl1/AABR07026311.1/AABR07063638.1/Chmp4bl1/LOC100360087/Glul/Parp1/Bax/RGD1560687
|
rno:100360087/rno:58940/rno:100360087/rno:679886/rno:100360087/rno:24957/rno:25591/rno:24887/rno:100360087
|
9
|
|
rno00053
|
Ascorbate and aldarate metabolism
|
1/344
|
12/7214
|
0.4438806
|
0.9902347
|
ENSRNOG00000014645
|
Aldh7a1
|
rno:291450
|
1
|
|
rno00130
|
Ubiquinone and other terpenoid-quinone biosynthesis
|
1/344
|
12/7214
|
0.4438806
|
0.9902347
|
ENSRNOG00000012772
|
Nqo1
|
rno:24314
|
1
|
|
rno04151
|
PI3K-Akt signaling pathway
|
17/344
|
339/7214
|
0.4510860
|
0.9902347
|
ENSRNOG00000012582/novel.1951/ENSRNOG00000016571/ENSRNOG00000014287/ENSRNOG00000020918/ENSRNOG00000053691/ENSRNOG00000018536/ENSRNOG00000058645/ENSRNOG00000049270/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000020573/ENSRNOG00000023972/ENSRNOG00000001409/ENSRNOG00000016611/ENSRNOG00000004276/ENSRNOG00000057451
|
Eif4ebp1/-/Ngf/Stk11/Ccnd1/Lama5/Pck2/Tnc/Ppp2r3b/Akt1/Bcl2l1/Efna1/Col4a2/Gnb2/Hras/Itga3/Itga5
|
rno:116636/rno:170851/rno:310738/rno:314621/rno:58919/rno:140433/rno:361042/rno:116640/rno:682033/rno:24185/rno:24888/rno:94268/rno:306628/rno:81667/rno:293621/rno:360606/rno:315346
|
17
|
|
rno04213
|
Longevity regulating pathway - multiple species
|
4/344
|
73/7214
|
0.4622861
|
0.9902347
|
ENSRNOG00000002115/ENSRNOG00000001142/ENSRNOG00000028629/ENSRNOG00000016611
|
Sod1/Prkab1/Akt1/Hras
|
rno:24786/rno:83803/rno:24185/rno:293621
|
4
|
|
rno04914
|
Progesterone-mediated oocyte maturation
|
5/344
|
94/7214
|
0.4673400
|
0.9902347
|
novel.1951/ENSRNOG00000018815/ENSRNOG00000003657/ENSRNOG00000028629/ENSRNOG00000001265
|
-/Plk1/Pkmyt1/Akt1/Mad1l1
|
rno:170851/rno:25515/rno:287101/rno:24185/rno:680006
|
5
|
|
rno00910
|
Nitrogen metabolism
|
1/344
|
13/7214
|
0.4704434
|
0.9902347
|
ENSRNOG00000049560
|
Glul
|
rno:24957
|
1
|
|
rno04137
|
Mitophagy - animal
|
4/344
|
74/7214
|
0.4728618
|
0.9902347
|
ENSRNOG00000007946/ENSRNOG00000019974/ENSRNOG00000009495/ENSRNOG00000016611
|
Bcl2l1/Uba52/Src/Hras
|
rno:24888/rno:64156/rno:83805/rno:293621
|
4
|
|
rno04150
|
mTOR signaling pathway
|
8/344
|
157/7214
|
0.4758514
|
0.9902347
|
ENSRNOG00000012582/novel.1951/ENSRNOG00000007392/ENSRNOG00000021962/ENSRNOG00000014287/ENSRNOG00000028629/ENSRNOG00000016611/ENSRNOG00000008163
|
Eif4ebp1/-/Atp6v1f/Fzd2/Stk11/Akt1/Hras/Atp6v1g1
|
rno:116636/rno:170851/rno:116664/rno:64512/rno:314621/rno:24185/rno:293621/rno:298103
|
8
|
|
rno05167
|
Kaposi sarcoma-associated herpesvirus infection
|
10/344
|
199/7214
|
0.4791567
|
0.9902347
|
novel.1951/ENSRNOG00000030871/ENSRNOG00000020918/ENSRNOG00000058388/ENSRNOG00000028629/ENSRNOG00000019974/ENSRNOG00000009495/ENSRNOG00000020876/ENSRNOG00000001409/ENSRNOG00000016611
|
-/Calm2/Ccnd1/Zfp36/Akt1/Uba52/Src/Bax/Gnb2/Hras
|
rno:170851/rno:24244/rno:58919/rno:79426/rno:24185/rno:64156/rno:83805/rno:24887/rno:81667/rno:293621
|
10
|
|
rno04115
|
p53 signaling pathway
|
4/344
|
75/7214
|
0.4833595
|
0.9902347
|
ENSRNOG00000013090/ENSRNOG00000020918/ENSRNOG00000007946/ENSRNOG00000020876
|
Gadd45g/Ccnd1/Bcl2l1/Bax
|
rno:291005/rno:58919/rno:24888/rno:24887
|
4
|
|
rno05152
|
Tuberculosis
|
8/344
|
159/7214
|
0.4902834
|
0.9902347
|
ENSRNOG00000057347/ENSRNOG00000030871/ENSRNOG00000018568/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000020876/ENSRNOG00000009867
|
Cebpb/Calm2/Rab5c/Tgfb1/Akt1/Src/Bax/Tgfb3
|
rno:24253/rno:24244/rno:287709/rno:59086/rno:24185/rno:83805/rno:24887/rno:25717
|
8
|
|
rno05323
|
Rheumatoid arthritis
|
4/344
|
76/7214
|
0.4937737
|
0.9902347
|
ENSRNOG00000007392/ENSRNOG00000020652/ENSRNOG00000009867/ENSRNOG00000008163
|
Atp6v1f/Tgfb1/Tgfb3/Atp6v1g1
|
rno:116664/rno:59086/rno:25717/rno:298103
|
4
|
|
rno05412
|
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
|
4/344
|
76/7214
|
0.4937737
|
0.9902347
|
ENSRNOG00000058882/ENSRNOG00000003998/ENSRNOG00000004276/ENSRNOG00000057451
|
Emd/Sgca/Itga3/Itga5
|
rno:25437/rno:303468/rno:360606/rno:315346
|
4
|
|
rno04672
|
Intestinal immune network for IgA production
|
2/344
|
35/7214
|
0.5026875
|
0.9902347
|
ENSRNOG00000020652/ENSRNOG00000019264
|
Tgfb1/Ltbr
|
rno:59086/rno:297604
|
2
|
|
rno05217
|
Basal cell carcinoma
|
3/344
|
56/7214
|
0.5037455
|
0.9902347
|
ENSRNOG00000013090/ENSRNOG00000021962/ENSRNOG00000020876
|
Gadd45g/Fzd2/Bax
|
rno:291005/rno:64512/rno:24887
|
3
|
|
rno04014
|
Ras signaling pathway
|
11/344
|
226/7214
|
0.5169742
|
0.9902347
|
novel.1951/ENSRNOG00000016571/ENSRNOG00000030871/ENSRNOG00000018568/ENSRNOG00000000474/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000020573/ENSRNOG00000001409/ENSRNOG00000016611/ENSRNOG00000050223
|
-/Ngf/Calm2/Rab5c/Rgl2/Akt1/Bcl2l1/Efna1/Gnb2/Hras/Rin1
|
rno:170851/rno:310738/rno:24244/rno:287709/rno:294283/rno:24185/rno:24888/rno:94268/rno:81667/rno:293621/rno:207119
|
11
|
|
rno00350
|
Tyrosine metabolism
|
2/344
|
36/7214
|
0.5178432
|
0.9902347
|
ENSRNOG00000002331/ENSRNOG00000001889
|
Aldh3a1/Comt
|
rno:25375/rno:24267
|
2
|
|
rno00513
|
Various types of N-glycan biosynthesis
|
2/344
|
36/7214
|
0.5178432
|
0.9902347
|
ENSRNOG00000004591/ENSRNOG00000031208
|
Alg12/Mgat1
|
rno:315212/rno:81519
|
2
|
|
rno04625
|
C-type lectin receptor signaling pathway
|
5/344
|
100/7214
|
0.5223774
|
0.9902347
|
ENSRNOG00000030871/ENSRNOG00000019311/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000016611
|
Calm2/Nfkb2/Akt1/Src/Hras
|
rno:24244/rno:309452/rno:24185/rno:83805/rno:293621
|
5
|
|
rno04146
|
Peroxisome
|
4/344
|
79/7214
|
0.5244670
|
0.9902347
|
ENSRNOG00000002115/ENSRNOG00000021125/ENSRNOG00000014522/ENSRNOG00000007081
|
Sod1/Prdx5/Mlycd/Xdh
|
rno:24786/rno:113898/rno:85239/rno:497811
|
4
|
|
rno04330
|
Notch signaling pathway
|
3/344
|
58/7214
|
0.5275607
|
0.9902347
|
ENSRNOG00000001250/ENSRNOG00000001004/ENSRNOG00000020867
|
Lfng/Ncor2/Numbl
|
rno:170905/rno:360801/rno:292732
|
3
|
|
rno00640
|
Propanoate metabolism
|
2/344
|
37/7214
|
0.5326892
|
0.9902347
|
ENSRNOG00000014522/ENSRNOG00000005587
|
Mlycd/Suclg1
|
rno:85239/rno:114597
|
2
|
|
rno04666
|
Fc gamma R-mediated phagocytosis
|
5/344
|
102/7214
|
0.5401858
|
0.9902347
|
ENSRNOG00000016367/novel.1951/ENSRNOG00000020660/ENSRNOG00000008994/ENSRNOG00000028629
|
Vasp/-/Cfl1/Arpc4/Akt1
|
rno:361517/rno:170851/rno:29271/rno:297518/rno:24185
|
5
|
|
rno04120
|
Ubiquitin mediated proteolysis
|
8/344
|
168/7214
|
0.5536640
|
0.9902347
|
ENSRNOG00000058914/ENSRNOG00000011663/ENSRNOG00000016930/ENSRNOG00000060530/ENSRNOG00000019798/ENSRNOG00000009409/ENSRNOG00000019974/ENSRNOG00000020230
|
Rbx1/Rnf7/Ube2s/Cdc34/Stub1/Fbxo2/Uba52/Pias4
|
rno:300084/rno:300948/rno:292588/rno:299602/rno:287155/rno:85273/rno:64156/rno:362827
|
8
|
|
rno04540
|
Gap junction
|
4/344
|
82/7214
|
0.5542442
|
0.9902347
|
novel.1951/ENSRNOG00000009495/ENSRNOG00000018371/ENSRNOG00000016611
|
-/Src/Tubb6/Hras
|
rno:170851/rno:83805/rno:307351/rno:293621
|
4
|
|
rno03030
|
DNA replication
|
2/344
|
39/7214
|
0.5614332
|
0.9902347
|
ENSRNOG00000020531/ENSRNOG00000014098
|
Fen1/Pold2
|
rno:84490/rno:289758
|
2
|
|
rno00770
|
Pantothenate and CoA biosynthesis
|
1/344
|
17/7214
|
0.5646289
|
0.9902347
|
ENSRNOG00000020956
|
Bcat2
|
rno:64203
|
1
|
|
rno04725
|
Cholinergic synapse
|
5/344
|
106/7214
|
0.5748453
|
0.9902347
|
novel.1951/ENSRNOG00000028629/novel.2043/ENSRNOG00000001409/ENSRNOG00000016611
|
-/Akt1/-/Gnb2/Hras
|
rno:170851/rno:24185/rno:259273/rno:81667/rno:293621
|
5
|
|
rno00051
|
Fructose and mannose metabolism
|
2/344
|
40/7214
|
0.5753247
|
0.9902347
|
ENSRNOG00000005358/ENSRNOG00000046891
|
Pmm1/Hk1
|
rno:300089/rno:25058
|
2
|
|
rno04931
|
Insulin resistance
|
5/344
|
107/7214
|
0.5832954
|
0.9902347
|
ENSRNOG00000010574/ENSRNOG00000018536/ENSRNOG00000001142/ENSRNOG00000028629/ENSRNOG00000018708
|
Ptpn1/Pck2/Prkab1/Akt1/Ppp1ca
|
rno:24697/rno:361042/rno:83803/rno:24185/rno:24668
|
5
|
|
rno05204
|
Chemical carcinogenesis
|
3/344
|
63/7214
|
0.5841989
|
0.9902347
|
ENSRNOG00000002331/ENSRNOG00000019500/ENSRNOG00000007743
|
Aldh3a1/Cyp1a1/Mgst1
|
rno:25375/rno:24296/rno:171341
|
3
|
|
rno01210
|
2-Oxocarboxylic acid metabolism
|
1/344
|
18/7214
|
0.5854387
|
0.9902347
|
ENSRNOG00000020956
|
Bcat2
|
rno:64203
|
1
|
|
rno04360
|
Axon guidance
|
8/344
|
173/7214
|
0.5874423
|
0.9902347
|
ENSRNOG00000020660/ENSRNOG00000045952/ENSRNOG00000024501/ENSRNOG00000020246/ENSRNOG00000020573/ENSRNOG00000009495/ENSRNOG00000018878/ENSRNOG00000016611
|
Cfl1/Ephb4/Rgs3/Myl9/Efna1/Src/Ssh3/Hras
|
rno:29271/rno:686310/rno:54293/rno:296313/rno:94268/rno:83805/rno:365396/rno:293621
|
8
|
|
rno00380
|
Tryptophan metabolism
|
2/344
|
41/7214
|
0.5888932
|
0.9902347
|
ENSRNOG00000019500/ENSRNOG00000014645
|
Cyp1a1/Aldh7a1
|
rno:24296/rno:291450
|
2
|
|
rno05135
|
Yersinia infection
|
6/344
|
130/7214
|
0.5919574
|
0.9902347
|
ENSRNOG00000019253/novel.1951/ENSRNOG00000001149/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000057451
|
Bcar1/-/Pxn/Akt1/Src/Itga5
|
rno:25414/rno:170851/rno:360820/rno:24185/rno:83805/rno:315346
|
6
|
|
rno01524
|
Platinum drug resistance
|
4/344
|
86/7214
|
0.5923538
|
0.9902347
|
ENSRNOG00000007743/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000020876
|
Mgst1/Akt1/Bcl2l1/Bax
|
rno:171341/rno:24185/rno:24888/rno:24887
|
4
|
|
rno04929
|
GnRH secretion
|
3/344
|
64/7214
|
0.5949975
|
0.9902347
|
novel.1951/ENSRNOG00000028629/ENSRNOG00000016611
|
-/Akt1/Hras
|
rno:170851/rno:24185/rno:293621
|
3
|
|
rno04728
|
Dopaminergic synapse
|
6/344
|
131/7214
|
0.5995152
|
0.9902347
|
ENSRNOG00000030871/ENSRNOG00000001889/ENSRNOG00000049270/ENSRNOG00000028629/ENSRNOG00000018708/ENSRNOG00000001409
|
Calm2/Comt/Ppp2r3b/Akt1/Ppp1ca/Gnb2
|
rno:24244/rno:24267/rno:682033/rno:24185/rno:24668/rno:81667
|
6
|
|
rno00360
|
Phenylalanine metabolism
|
1/344
|
19/7214
|
0.6052565
|
0.9902347
|
ENSRNOG00000002331
|
Aldh3a1
|
rno:25375
|
1
|
|
rno05206
|
MicroRNAs in cancer
|
8/344
|
177/7214
|
0.6135674
|
0.9902347
|
novel.1951/ENSRNOG00000056585/ENSRNOG00000020918/ENSRNOG00000018524/ENSRNOG00000058645/ENSRNOG00000020573/ENSRNOG00000016611/ENSRNOG00000057451
|
-/Fscn1/Ccnd1/Ezr/Tnc/Efna1/Hras/Itga5
|
rno:170851/rno:683788/rno:58919/rno:54319/rno:116640/rno:94268/rno:293621/rno:315346
|
8
|
|
rno00230
|
Purine metabolism
|
6/344
|
133/7214
|
0.6144039
|
0.9902347
|
ENSRNOG00000048561/ENSRNOG00000002693/ENSRNOG00000026519/ENSRNOG00000007081/ENSRNOG00000019240/ENSRNOG00000014405
|
Hprt1/Nme1/AABR07044711.1/Xdh/Ampd2/Aprt
|
rno:103689983/rno:191575/rno:100364062/rno:497811/rno:362015/rno:292072
|
6
|
|
rno05144
|
Malaria
|
2/344
|
43/7214
|
0.6150584
|
0.9902347
|
ENSRNOG00000020652/ENSRNOG00000009867
|
Tgfb1/Tgfb3
|
rno:59086/rno:25717
|
2
|
|
rno04664
|
Fc epsilon RI signaling pathway
|
3/344
|
66/7214
|
0.6160427
|
0.9902347
|
novel.1951/ENSRNOG00000028629/ENSRNOG00000016611
|
-/Akt1/Hras
|
rno:170851/rno:24185/rno:293621
|
3
|
|
rno00220
|
Arginine biosynthesis
|
1/344
|
20/7214
|
0.6241296
|
0.9902347
|
ENSRNOG00000049560
|
Glul
|
rno:24957
|
1
|
|
rno04022
|
cGMP-PKG signaling pathway
|
7/344
|
157/7214
|
0.6272220
|
0.9902347
|
ENSRNOG00000016367/novel.1951/ENSRNOG00000030871/ENSRNOG00000020246/ENSRNOG00000018232/ENSRNOG00000028629/ENSRNOG00000018708
|
Vasp/-/Calm2/Myl9/Srf/Akt1/Ppp1ca
|
rno:361517/rno:170851/rno:24244/rno:296313/rno:501099/rno:24185/rno:24668
|
7
|
|
rno04390
|
Hippo signaling pathway
|
7/344
|
157/7214
|
0.6272220
|
0.9902347
|
ENSRNOG00000021962/ENSRNOG00000020918/ENSRNOG00000020652/ENSRNOG00000012791/ENSRNOG00000018359/ENSRNOG00000009867/ENSRNOG00000018708
|
Fzd2/Ccnd1/Tgfb1/Ajuba/Smad7/Tgfb3/Ppp1ca
|
rno:64512/rno:58919/rno:59086/rno:85265/rno:81516/rno:25717/rno:24668
|
7
|
|
rno04916
|
Melanogenesis
|
4/344
|
90/7214
|
0.6284819
|
0.9902347
|
novel.1951/ENSRNOG00000021962/ENSRNOG00000030871/ENSRNOG00000016611
|
-/Fzd2/Calm2/Hras
|
rno:170851/rno:64512/rno:24244/rno:293621
|
4
|
|
rno04668
|
TNF signaling pathway
|
5/344
|
113/7214
|
0.6320271
|
0.9902347
|
ENSRNOG00000042838/ENSRNOG00000057347/novel.1951/ENSRNOG00000010947/ENSRNOG00000028629
|
Junb/Cebpb/-/Mmp14/Akt1
|
rno:24517/rno:24253/rno:170851/rno:81707/rno:24185
|
5
|
|
rno05133
|
Pertussis
|
3/344
|
68/7214
|
0.6363395
|
0.9902347
|
ENSRNOG00000020660/ENSRNOG00000030871/ENSRNOG00000057451
|
Cfl1/Calm2/Itga5
|
rno:29271/rno:24244/rno:315346
|
3
|
|
rno00100
|
Steroid biosynthesis
|
1/344
|
21/7214
|
0.6421028
|
0.9902347
|
ENSRNOG00000006787
|
Dhcr24
|
rno:298298
|
1
|
|
rno00564
|
Glycerophospholipid metabolism
|
4/344
|
93/7214
|
0.6542035
|
0.9902347
|
ENSRNOG00000010067/ENSRNOG00000001205/ENSRNOG00000018390/ENSRNOG00000036684
|
Lypla2/Agpat3/Pld3/Pcyt2
|
rno:83510/rno:294324/rno:361527/rno:89841
|
4
|
|
rno03320
|
PPAR signaling pathway
|
3/344
|
70/7214
|
0.6558781
|
0.9902347
|
ENSRNOG00000046889/ENSRNOG00000018536/ENSRNOG00000000464
|
Dbi/Pck2/Rxrb
|
rno:25045/rno:361042/rno:361801
|
3
|
|
rno00670
|
One carbon pool by folate
|
1/344
|
22/7214
|
0.6592190
|
0.9902347
|
ENSRNOG00000008106
|
Shmt2
|
rno:299857
|
1
|
|
rno04744
|
Phototransduction
|
1/344
|
22/7214
|
0.6592190
|
0.9902347
|
ENSRNOG00000030871
|
Calm2
|
rno:24244
|
1
|
|
rno04964
|
Proximal tubule bicarbonate reclamation
|
1/344
|
22/7214
|
0.6592190
|
0.9902347
|
ENSRNOG00000018536
|
Pck2
|
rno:361042
|
1
|
|
rno04935
|
Growth hormone synthesis, secretion and action
|
5/344
|
117/7214
|
0.6625221
|
0.9902347
|
ENSRNOG00000042838/ENSRNOG00000019253/novel.1951/ENSRNOG00000028629/ENSRNOG00000016611
|
Junb/Bcar1/-/Akt1/Hras
|
rno:24517/rno:25414/rno:170851/rno:24185/rno:293621
|
5
|
|
rno00982
|
Drug metabolism - cytochrome P450
|
2/344
|
47/7214
|
0.6635250
|
0.9902347
|
ENSRNOG00000002331/ENSRNOG00000007743
|
Aldh3a1/Mgst1
|
rno:25375/rno:171341
|
2
|
|
rno04979
|
Cholesterol metabolism
|
2/344
|
47/7214
|
0.6635250
|
0.9902347
|
ENSRNOG00000009946/ENSRNOG00000012062
|
Ldlr/Npc2
|
rno:300438/rno:286898
|
2
|
|
rno05321
|
Inflammatory bowel disease (IBD)
|
2/344
|
47/7214
|
0.6635250
|
0.9902347
|
ENSRNOG00000020652/ENSRNOG00000009867
|
Tgfb1/Tgfb3
|
rno:59086/rno:25717
|
2
|
|
rno04010
|
MAPK signaling pathway
|
13/344
|
297/7214
|
0.6668152
|
0.9902347
|
novel.1951/ENSRNOG00000013090/ENSRNOG00000016571/ENSRNOG00000019568/ENSRNOG00000018232/ENSRNOG00000019311/ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000007281/ENSRNOG00000020573/ENSRNOG00000019964/ENSRNOG00000009867/ENSRNOG00000016611
|
-/Gadd45g/Ngf/Jund/Srf/Nfkb2/Tgfb1/Akt1/Flnc/Efna1/Taok2/Tgfb3/Hras
|
rno:170851/rno:291005/rno:310738/rno:24518/rno:501099/rno:309452/rno:59086/rno:24185/rno:362332/rno:94268/rno:64666/rno:25717/rno:293621
|
13
|
|
rno04350
|
TGF-beta signaling pathway
|
4/344
|
95/7214
|
0.6706777
|
0.9902347
|
ENSRNOG00000058914/ENSRNOG00000020652/ENSRNOG00000018359/ENSRNOG00000009867
|
Rbx1/Tgfb1/Smad7/Tgfb3
|
rno:300084/rno:59086/rno:81516/rno:25717
|
4
|
|
rno04662
|
B cell receptor signaling pathway
|
3/344
|
72/7214
|
0.6746537
|
0.9902347
|
novel.1951/ENSRNOG00000028629/ENSRNOG00000016611
|
-/Akt1/Hras
|
rno:170851/rno:24185/rno:293621
|
3
|
|
rno00140
|
Steroid hormone biosynthesis
|
2/344
|
48/7214
|
0.6748487
|
0.9902347
|
ENSRNOG00000019500/ENSRNOG00000001889
|
Cyp1a1/Comt
|
rno:24296/rno:24267
|
2
|
|
rno00515
|
Mannose type O-glycan biosynthesis
|
1/344
|
23/7214
|
0.6755188
|
0.9902347
|
ENSRNOG00000023455
|
Pomgnt1
|
rno:362567
|
1
|
|
rno00601
|
Glycosphingolipid biosynthesis - lacto and neolacto series
|
1/344
|
23/7214
|
0.6755188
|
0.9902347
|
ENSRNOG00000023778
|
Gcnt2
|
rno:689092
|
1
|
|
rno00650
|
Butanoate metabolism
|
1/344
|
23/7214
|
0.6755188
|
0.9902347
|
ENSRNOG00000000967
|
Aacs
|
rno:65984
|
1
|
|
rno05231
|
Choline metabolism in cancer
|
4/344
|
96/7214
|
0.6787104
|
0.9902347
|
ENSRNOG00000012582/novel.1951/ENSRNOG00000028629/ENSRNOG00000016611
|
Eif4ebp1/-/Akt1/Hras
|
rno:116636/rno:170851/rno:24185/rno:293621
|
4
|
|
rno04261
|
Adrenergic signaling in cardiomyocytes
|
6/344
|
143/7214
|
0.6839816
|
0.9902347
|
ENSRNOG00000030871/ENSRNOG00000015049/ENSRNOG00000049270/ENSRNOG00000028629/ENSRNOG00000033734/ENSRNOG00000018708
|
Calm2/Scn5a/Ppp2r3b/Akt1/Tnnt2/Ppp1ca
|
rno:24244/rno:25665/rno:682033/rno:24185/rno:24837/rno:24668
|
6
|
|
rno04930
|
Type II diabetes mellitus
|
2/344
|
49/7214
|
0.6858614
|
0.9902347
|
ENSRNOG00000026519/ENSRNOG00000046891
|
AABR07044711.1/Hk1
|
rno:100364062/rno:25058
|
2
|
|
rno04961
|
Endocrine and other factor-regulated calcium reabsorption
|
2/344
|
49/7214
|
0.6858614
|
0.9902347
|
ENSRNOG00000017506/ENSRNOG00000014635
|
Cltb/Clta
|
rno:116561/rno:83800
|
2
|
|
rno03018
|
RNA degradation
|
4/344
|
97/7214
|
0.6866061
|
0.9902347
|
ENSRNOG00000019572/ENSRNOG00000019552/ENSRNOG00000030374/ENSRNOG00000003300
|
Lsm4/Lsm7/LOC100360750/Btg2
|
rno:290647/rno:362829/rno:100360750/rno:29619
|
4
|
|
rno04750
|
Inflammatory mediator regulation of TRP channels
|
4/344
|
98/7214
|
0.6943646
|
0.9902347
|
ENSRNOG00000016571/ENSRNOG00000030871/ENSRNOG00000009495/ENSRNOG00000018708
|
Ngf/Calm2/Src/Ppp1ca
|
rno:310738/rno:24244/rno:83805/rno:24668
|
4
|
|
rno04928
|
Parathyroid hormone synthesis, secretion and action
|
4/344
|
99/7214
|
0.7019856
|
0.9902347
|
novel.1951/ENSRNOG00000019568/ENSRNOG00000010947/ENSRNOG00000000464
|
-/Jund/Mmp14/Rxrb
|
rno:170851/rno:24518/rno:81707/rno:361801
|
4
|
|
rno03430
|
Mismatch repair
|
1/344
|
25/7214
|
0.7058231
|
0.9902347
|
ENSRNOG00000014098
|
Pold2
|
rno:289758
|
1
|
|
rno04723
|
Retrograde endocannabinoid signaling
|
6/344
|
147/7214
|
0.7094072
|
0.9902347
|
ENSRNOG00000020602/ENSRNOG00000006939/ENSRNOG00000048320/ENSRNOG00000024539/ENSRNOG00000029339/ENSRNOG00000001409
|
Ndufa13/Ndufa7/Ndufa11/Ndufb6/LOC100363268/Gnb2
|
rno:100911483/rno:299643/rno:301123/rno:297990/rno:100363268/rno:81667
|
6
|
|
rno05134
|
Legionellosis
|
3/344
|
76/7214
|
0.7099193
|
0.9902347
|
ENSRNOG00000050510/ENSRNOG00000019311/ENSRNOG00000020075
|
LOC100363782/Nfkb2/Eef1g
|
rno:100363782/rno:309452/rno:293725
|
3
|
|
rno04142
|
Lysosome
|
5/344
|
124/7214
|
0.7118275
|
0.9902347
|
ENSRNOG00000014992/ENSRNOG00000017506/ENSRNOG00000012062/ENSRNOG00000014635/ENSRNOG00000001415
|
M6pr/Cltb/Npc2/Clta/Ap1s1
|
rno:100909548/rno:116561/rno:286898/rno:83800/rno:360785
|
5
|
|
rno01200
|
Carbon metabolism
|
6/344
|
148/7214
|
0.7155419
|
0.9902347
|
ENSRNOG00000017523/ENSRNOG00000030963/ENSRNOG00000026519/ENSRNOG00000046891/ENSRNOG00000008106/ENSRNOG00000005587
|
H6pd/LOC685186/AABR07044711.1/Hk1/Shmt2/Suclg1
|
rno:298655/rno:24383/rno:100364062/rno:25058/rno:299857/rno:114597
|
6
|
|
rno05215
|
Prostate cancer
|
4/344
|
101/7214
|
0.7168157
|
0.9902347
|
novel.1951/ENSRNOG00000020918/ENSRNOG00000028629/ENSRNOG00000016611
|
-/Ccnd1/Akt1/Hras
|
rno:170851/rno:58919/rno:24185/rno:293621
|
4
|
|
rno03420
|
Nucleotide excision repair
|
2/344
|
52/7214
|
0.7170735
|
0.9902347
|
ENSRNOG00000058914/ENSRNOG00000014098
|
Rbx1/Pold2
|
rno:300084/rno:289758
|
2
|
|
rno00563
|
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis
|
1/344
|
26/7214
|
0.7198997
|
0.9902347
|
ENSRNOG00000049110
|
Dpm2
|
rno:29640
|
1
|
|
rno05034
|
Alcoholism
|
7/344
|
173/7214
|
0.7255445
|
0.9902347
|
novel.1951/ENSRNOG00000030871/ENSRNOG00000038375/ENSRNOG00000055597/ENSRNOG00000018708/ENSRNOG00000001409/ENSRNOG00000016611
|
-/Calm2/AABR07026311.1/Hdac7/Ppp1ca/Gnb2/Hras
|
rno:170851/rno:24244/rno:58940/rno:84582/rno:24668/rno:81667/rno:293621
|
7
|
|
rno04727
|
GABAergic synapse
|
3/344
|
78/7214
|
0.7264206
|
0.9902347
|
ENSRNOG00000049560/ENSRNOG00000009495/ENSRNOG00000001409
|
Glul/Src/Gnb2
|
rno:24957/rno:83805/rno:81667
|
3
|
|
rno00030
|
Pentose phosphate pathway
|
1/344
|
27/7214
|
0.7333047
|
0.9902347
|
ENSRNOG00000017523
|
H6pd
|
rno:298655
|
1
|
|
rno00500
|
Starch and sucrose metabolism
|
1/344
|
27/7214
|
0.7333047
|
0.9902347
|
ENSRNOG00000046891
|
Hk1
|
rno:25058
|
1
|
|
rno04550
|
Signaling pathways regulating pluripotency of stem cells
|
5/344
|
128/7214
|
0.7376332
|
0.9902347
|
novel.1951/ENSRNOG00000021962/ENSRNOG00000028629/ENSRNOG00000051499/ENSRNOG00000016611
|
-/Fzd2/Akt1/Tcf3/Hras
|
rno:170851/rno:64512/rno:24185/rno:171046/rno:293621
|
5
|
|
rno05160
|
Hepatitis C
|
6/344
|
152/7214
|
0.7391874
|
0.9902347
|
novel.1951/ENSRNOG00000020918/ENSRNOG00000009946/ENSRNOG00000028629/ENSRNOG00000020876/ENSRNOG00000016611
|
-/Ccnd1/Ldlr/Akt1/Bax/Hras
|
rno:170851/rno:58919/rno:300438/rno:24185/rno:24887/rno:293621
|
6
|
|
rno04071
|
Sphingolipid signaling pathway
|
5/344
|
129/7214
|
0.7438149
|
0.9902347
|
novel.1951/ENSRNOG00000049270/ENSRNOG00000028629/ENSRNOG00000020876/ENSRNOG00000016611
|
-/Ppp2r3b/Akt1/Bax/Hras
|
rno:170851/rno:682033/rno:24185/rno:24887/rno:293621
|
5
|
|
rno00561
|
Glycerolipid metabolism
|
2/344
|
55/7214
|
0.7456424
|
0.9902347
|
ENSRNOG00000001205/ENSRNOG00000014645
|
Agpat3/Aldh7a1
|
rno:294324/rno:291450
|
2
|
|
rno05416
|
Viral myocarditis
|
3/344
|
81/7214
|
0.7497864
|
0.9902347
|
ENSRNOG00000030704/ENSRNOG00000020918/ENSRNOG00000003998
|
LOC100911693/Ccnd1/Sgca
|
rno:287986/rno:58919/rno:303468
|
3
|
|
rno04915
|
Estrogen signaling pathway
|
5/344
|
131/7214
|
0.7558564
|
0.9902347
|
novel.1951/ENSRNOG00000030871/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000016611
|
-/Calm2/Akt1/Src/Hras
|
rno:170851/rno:24244/rno:24185/rno:83805/rno:293621
|
5
|
|
rno00790
|
Folate biosynthesis
|
1/344
|
29/7214
|
0.7582257
|
0.9902347
|
ENSRNOG00000047796
|
Pcbd2
|
rno:685729
|
1
|
|
rno04392
|
Hippo signaling pathway - multiple species
|
1/344
|
29/7214
|
0.7582257
|
0.9902347
|
ENSRNOG00000012791
|
Ajuba
|
rno:85265
|
1
|
|
rno00860
|
Porphyrin and chlorophyll metabolism
|
1/344
|
30/7214
|
0.7698012
|
0.9902347
|
ENSRNOG00000024410
|
Blvrb
|
rno:292737
|
1
|
|
rno00240
|
Pyrimidine metabolism
|
2/344
|
59/7214
|
0.7798637
|
0.9902347
|
ENSRNOG00000002693/ENSRNOG00000003917
|
Nme1/Uck2
|
rno:191575/rno:304944
|
2
|
|
rno00270
|
Cysteine and methionine metabolism
|
2/344
|
59/7214
|
0.7798637
|
0.9902347
|
ENSRNOG00000026211/ENSRNOG00000020956
|
Mri1/Bcat2
|
rno:288912/rno:64203
|
2
|
|
rno04630
|
JAK-STAT signaling pathway
|
5/344
|
136/7214
|
0.7841036
|
0.9902347
|
ENSRNOG00000020918/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000016611/ENSRNOG00000020230
|
Ccnd1/Akt1/Bcl2l1/Hras/Pias4
|
rno:58919/rno:24185/rno:24888/rno:293621/rno:362827
|
5
|
|
rno04730
|
Long-term depression
|
2/344
|
60/7214
|
0.7877648
|
0.9902347
|
novel.1951/ENSRNOG00000016611
|
-/Hras
|
rno:170851/rno:293621
|
2
|
|
rno05031
|
Amphetamine addiction
|
2/344
|
61/7214
|
0.7954157
|
0.9902347
|
ENSRNOG00000030871/ENSRNOG00000018708
|
Calm2/Ppp1ca
|
rno:24244/rno:24668
|
2
|
|
rno05235
|
PD-L1 expression and PD-1 checkpoint pathway in cancer
|
3/344
|
89/7214
|
0.8043244
|
0.9902347
|
novel.1951/ENSRNOG00000028629/ENSRNOG00000016611
|
-/Akt1/Hras
|
rno:170851/rno:24185/rno:293621
|
3
|
|
rno00760
|
Nicotinate and nicotinamide metabolism
|
1/344
|
34/7214
|
0.8108337
|
0.9902347
|
ENSRNOG00000006393
|
Sirt6
|
rno:299638
|
1
|
|
rno01523
|
Antifolate resistance
|
1/344
|
34/7214
|
0.8108337
|
0.9902347
|
ENSRNOG00000008106
|
Shmt2
|
rno:299857
|
1
|
|
rno04145
|
Phagosome
|
6/344
|
167/7214
|
0.8152639
|
0.9902347
|
ENSRNOG00000007392/ENSRNOG00000014992/ENSRNOG00000018568/ENSRNOG00000018371/ENSRNOG00000057451/ENSRNOG00000008163
|
Atp6v1f/M6pr/Rab5c/Tubb6/Itga5/Atp6v1g1
|
rno:116664/rno:100909548/rno:287709/rno:307351/rno:315346/rno:298103
|
6
|
|
rno00250
|
Alanine, aspartate and glutamate metabolism
|
1/344
|
35/7214
|
0.8198968
|
0.9902347
|
ENSRNOG00000049560
|
Glul
|
rno:24957
|
1
|
|
rno00514
|
Other types of O-glycan biosynthesis
|
1/344
|
35/7214
|
0.8198968
|
0.9902347
|
ENSRNOG00000001250
|
Lfng
|
rno:170905
|
1
|
|
rno04130
|
SNARE interactions in vesicular transport
|
1/344
|
35/7214
|
0.8198968
|
0.9902347
|
ENSRNOG00000019302
|
Stx4
|
rno:81803
|
1
|
|
rno04971
|
Gastric acid secretion
|
2/344
|
65/7214
|
0.8236339
|
0.9902347
|
ENSRNOG00000030871/ENSRNOG00000018524
|
Calm2/Ezr
|
rno:24244/rno:54319
|
2
|
|
rno04659
|
Th17 cell differentiation
|
3/344
|
93/7214
|
0.8276351
|
0.9902347
|
ENSRNOG00000020652/ENSRNOG00000001704/ENSRNOG00000000464
|
Tgfb1/Runx1/Rxrb
|
rno:59086/rno:50662/rno:361801
|
3
|
|
rno04934
|
Cushing syndrome
|
5/344
|
146/7214
|
0.8329445
|
0.9902347
|
novel.1951/ENSRNOG00000021962/ENSRNOG00000020918/ENSRNOG00000009946/ENSRNOG00000022289
|
-/Fzd2/Ccnd1/Ldlr/Aip
|
rno:170851/rno:64512/rno:58919/rno:300438/rno:282827
|
5
|
|
rno04611
|
Platelet activation
|
4/344
|
123/7214
|
0.8452895
|
0.9902347
|
ENSRNOG00000016367/ENSRNOG00000028629/ENSRNOG00000009495/ENSRNOG00000018708
|
Vasp/Akt1/Src/Ppp1ca
|
rno:361517/rno:24185/rno:83805/rno:24668
|
4
|
|
rno05140
|
Leishmaniasis
|
2/344
|
69/7214
|
0.8483134
|
0.9902347
|
ENSRNOG00000020652/ENSRNOG00000009867
|
Tgfb1/Tgfb3
|
rno:59086/rno:25717
|
2
|
|
rno00071
|
Fatty acid degradation
|
1/344
|
39/7214
|
0.8520205
|
0.9902347
|
ENSRNOG00000014645
|
Aldh7a1
|
rno:291450
|
1
|
|
rno05142
|
Chagas disease (American trypanosomiasis)
|
3/344
|
98/7214
|
0.8534016
|
0.9902347
|
ENSRNOG00000020652/ENSRNOG00000028629/ENSRNOG00000009867
|
Tgfb1/Akt1/Tgfb3
|
rno:59086/rno:24185/rno:25717
|
3
|
|
rno04310
|
Wnt signaling pathway
|
5/344
|
151/7214
|
0.8537775
|
0.9902347
|
ENSRNOG00000058914/ENSRNOG00000024429/ENSRNOG00000021962/ENSRNOG00000020918/ENSRNOG00000009656
|
Rbx1/Peg12/Fzd2/Ccnd1/Rspo1
|
rno:300084/rno:308692/rno:64512/rno:58919/rno:313589
|
5
|
|
rno04726
|
Serotonergic synapse
|
3/344
|
99/7214
|
0.8581333
|
0.9902347
|
novel.1951/ENSRNOG00000001409/ENSRNOG00000016611
|
-/Gnb2/Hras
|
rno:170851/rno:81667/rno:293621
|
3
|
|
rno04640
|
Hematopoietic cell lineage
|
2/344
|
71/7214
|
0.8594403
|
0.9902347
|
ENSRNOG00000004276/ENSRNOG00000057451
|
Itga3/Itga5
|
rno:360606/rno:315346
|
2
|
|
rno04660
|
T cell receptor signaling pathway
|
3/344
|
101/7214
|
0.8671980
|
0.9902347
|
novel.1951/ENSRNOG00000028629/ENSRNOG00000016611
|
-/Akt1/Hras
|
rno:170851/rno:24185/rno:293621
|
3
|
|
rno00310
|
Lysine degradation
|
2/344
|
73/7214
|
0.8698175
|
0.9902347
|
ENSRNOG00000014645/ENSRNOG00000001337
|
Aldh7a1/Setd1b
|
rno:291450/rno:100359816
|
2
|
|
rno00565
|
Ether lipid metabolism
|
1/344
|
42/7214
|
0.8723034
|
0.9902347
|
ENSRNOG00000018390
|
Pld3
|
rno:361527
|
1
|
|
rno05030
|
Cocaine addiction
|
1/344
|
42/7214
|
0.8723034
|
0.9902347
|
ENSRNOG00000018666
|
Gpsm1
|
rno:246254
|
1
|
|
rno04140
|
Autophagy - animal
|
5/344
|
158/7214
|
0.8792819
|
0.9902347
|
novel.1951/ENSRNOG00000014287/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000016611
|
-/Stk11/Akt1/Bcl2l1/Hras
|
rno:170851/rno:314621/rno:24185/rno:24888/rno:293621
|
5
|
|
rno00830
|
Retinol metabolism
|
1/344
|
44/7214
|
0.8842602
|
0.9902347
|
ENSRNOG00000019500
|
Cyp1a1
|
rno:24296
|
1
|
|
rno04340
|
Hedgehog signaling pathway
|
1/344
|
45/7214
|
0.8898131
|
0.9902347
|
ENSRNOG00000020918
|
Ccnd1
|
rno:58919
|
1
|
|
rno05032
|
Morphine addiction
|
2/344
|
79/7214
|
0.8968706
|
0.9902347
|
ENSRNOG00000014615/ENSRNOG00000001409
|
Grk6/Gnb2
|
rno:59076/rno:81667
|
2
|
|
rno04072
|
Phospholipase D signaling pathway
|
4/344
|
137/7214
|
0.8983655
|
0.9902347
|
novel.1951/ENSRNOG00000001205/ENSRNOG00000028629/ENSRNOG00000016611
|
-/Agpat3/Akt1/Hras
|
rno:170851/rno:294324/rno:24185/rno:293621
|
4
|
|
rno04657
|
IL-17 signaling pathway
|
2/344
|
81/7214
|
0.9046611
|
0.9902347
|
ENSRNOG00000057347/ENSRNOG00000019568
|
Cebpb/Jund
|
rno:24253/rno:24518
|
2
|
|
rno03022
|
Basal transcription factors
|
1/344
|
48/7214
|
0.9049279
|
0.9902347
|
ENSRNOG00000047134
|
Gtf2f1
|
rno:316123
|
1
|
|
rno04974
|
Protein digestion and absorption
|
2/344
|
82/7214
|
0.9083473
|
0.9902347
|
ENSRNOG00000023972/ENSRNOG00000020525
|
Col4a2/Col5a3
|
rno:306628/rno:60379
|
2
|
|
rno04623
|
Cytosolic DNA-sensing pathway
|
1/344
|
49/7214
|
0.9094918
|
0.9902347
|
ENSRNOG00000019079
|
Polr1c
|
rno:301246
|
1
|
|
rno04650
|
Natural killer cell mediated cytotoxicity
|
2/344
|
84/7214
|
0.9153238
|
0.9902347
|
novel.1951/ENSRNOG00000016611
|
-/Hras
|
rno:170851/rno:293621
|
2
|
|
rno04620
|
Toll-like receptor signaling pathway
|
2/344
|
86/7214
|
0.9218003
|
0.9902347
|
novel.1951/ENSRNOG00000028629
|
-/Akt1
|
rno:170851/rno:24185
|
2
|
|
rno04713
|
Circadian entrainment
|
2/344
|
86/7214
|
0.9218003
|
0.9902347
|
ENSRNOG00000030871/ENSRNOG00000001409
|
Calm2/Gnb2
|
rno:24244/rno:81667
|
2
|
|
rno05168
|
Herpes simplex virus 1 infection
|
13/344
|
379/7214
|
0.9218467
|
0.9902347
|
ENSRNOG00000012582/ENSRNOG00000001163/ENSRNOG00000033639/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000001039/ENSRNOG00000029490/ENSRNOG00000009495/ENSRNOG00000020876/ENSRNOG00000010007/ENSRNOG00000018708/ENSRNOG00000057451/ENSRNOG00000029500
|
Eif4ebp1/Srsf9/Zfp777/Akt1/Bcl2l1/Eif2b1/LOC102553763/Src/Bax/Srsf4/Ppp1ca/Itga5/Tapbp
|
rno:116636/rno:288701/rno:502764/rno:24185/rno:24888/rno:64514/rno:102553763/rno:83805/rno:24887/rno:362612/rno:24668/rno:315346/rno:25217
|
13
|
|
rno05162
|
Measles
|
4/344
|
146/7214
|
0.9233713
|
0.9902347
|
ENSRNOG00000020918/ENSRNOG00000028629/ENSRNOG00000007946/ENSRNOG00000020876
|
Ccnd1/Akt1/Bcl2l1/Bax
|
rno:58919/rno:24185/rno:24888/rno:24887
|
4
|
|
rno03460
|
Fanconi anemia pathway
|
1/344
|
53/7214
|
0.9256644
|
0.9902347
|
ENSRNOG00000020617
|
Mus81
|
rno:293678
|
1
|
|
rno04923
|
Regulation of lipolysis in adipocytes
|
1/344
|
53/7214
|
0.9256644
|
0.9902347
|
ENSRNOG00000028629
|
Akt1
|
rno:24185
|
1
|
|
rno04061
|
Viral protein interaction with cytokine and cytokine receptor
|
1/344
|
54/7214
|
0.9292353
|
0.9902347
|
ENSRNOG00000019264
|
Ltbr
|
rno:297604
|
1
|
|
rno04925
|
Aldosterone synthesis and secretion
|
2/344
|
91/7214
|
0.9360123
|
0.9902347
|
ENSRNOG00000030871/ENSRNOG00000009946
|
Calm2/Ldlr
|
rno:24244/rno:300438
|
2
|
|
rno04724
|
Glutamatergic synapse
|
2/344
|
94/7214
|
0.9433283
|
0.9902347
|
ENSRNOG00000049560/ENSRNOG00000001409
|
Glul/Gnb2
|
rno:24957/rno:81667
|
2
|
|
rno00480
|
Glutathione metabolism
|
1/344
|
59/7214
|
0.9446817
|
0.9902347
|
ENSRNOG00000007743
|
Mgst1
|
rno:171341
|
1
|
|
rno04924
|
Renin secretion
|
1/344
|
59/7214
|
0.9446817
|
0.9902347
|
ENSRNOG00000030871
|
Calm2
|
rno:24244
|
1
|
|
rno04927
|
Cortisol synthesis and secretion
|
1/344
|
59/7214
|
0.9446817
|
0.9902347
|
ENSRNOG00000009946
|
Ldlr
|
rno:300438
|
1
|
|
rno00590
|
Arachidonic acid metabolism
|
1/344
|
60/7214
|
0.9473413
|
0.9902347
|
ENSRNOG00000001701
|
Cbr3
|
rno:304078
|
1
|
|
rno04070
|
Phosphatidylinositol signaling system
|
2/344
|
97/7214
|
0.9498458
|
0.9902347
|
ENSRNOG00000030871/ENSRNOG00000003033
|
Calm2/Plcd3
|
rno:24244/rno:287745
|
2
|
|
rno04024
|
cAMP signaling pathway
|
5/344
|
189/7214
|
0.9515676
|
0.9902347
|
novel.1951/ENSRNOG00000030871/ENSRNOG00000020246/ENSRNOG00000028629/ENSRNOG00000018708
|
-/Calm2/Myl9/Akt1/Ppp1ca
|
rno:170851/rno:24244/rno:296313/rno:24185/rno:24668
|
5
|
|
rno01212
|
Fatty acid metabolism
|
1/344
|
62/7214
|
0.9522841
|
0.9902347
|
ENSRNOG00000021808
|
Tecr
|
rno:191576
|
1
|
|
rno04976
|
Bile secretion
|
1/344
|
62/7214
|
0.9522841
|
0.9902347
|
ENSRNOG00000009946
|
Ldlr
|
rno:300438
|
1
|
|
rno04060
|
Cytokine-cytokine receptor interaction
|
5/344
|
191/7214
|
0.9544861
|
0.9902347
|
ENSRNOG00000016571/ENSRNOG00000003546/ENSRNOG00000020652/ENSRNOG00000019264/ENSRNOG00000009867
|
Ngf/Tnfrsf12a/Tgfb1/Ltbr/Tgfb3
|
rno:310738/rno:302965/rno:59086/rno:297604/rno:25717
|
5
|
|
rno05322
|
Systemic lupus erythematosus
|
2/344
|
103/7214
|
0.9608020
|
0.9930678
|
ENSRNOG00000038375/ENSRNOG00000020433
|
AABR07026311.1/Actn4
|
rno:58940/rno:63836
|
2
|
|
rno04970
|
Salivary secretion
|
1/344
|
68/7214
|
0.9645048
|
0.9931890
|
ENSRNOG00000030871
|
Calm2
|
rno:24244
|
1
|
|
rno05164
|
Influenza A
|
3/344
|
144/7214
|
0.9711893
|
0.9963683
|
novel.1951/ENSRNOG00000028629/ENSRNOG00000020876
|
-/Akt1/Bax
|
rno:170851/rno:24185/rno:24887
|
3
|
|
rno00562
|
Inositol phosphate metabolism
|
1/344
|
80/7214
|
0.9803732
|
0.9987846
|
ENSRNOG00000003033
|
Plcd3
|
rno:287745
|
1
|
|
rno04612
|
Antigen processing and presentation
|
1/344
|
91/7214
|
0.9886084
|
0.9987846
|
ENSRNOG00000029500
|
Tapbp
|
rno:25217
|
1
|
|
rno04020
|
Calcium signaling pathway
|
3/344
|
176/7214
|
0.9916416
|
0.9987846
|
ENSRNOG00000030871/ENSRNOG00000003033/ENSRNOG00000004094
|
Calm2/Plcd3/Ptger1
|
rno:24244/rno:287745/rno:25637
|
3
|
|
rno04514
|
Cell adhesion molecules (CAMs)
|
2/344
|
140/7214
|
0.9918533
|
0.9987846
|
ENSRNOG00000027954/ENSRNOG00000018730
|
Cdh15/Pvrl2
|
rno:361432/rno:308417
|
2
|
|
rno04740
|
Olfactory transduction
|
1/344
|
106/7214
|
0.9945825
|
0.9987846
|
ENSRNOG00000030871
|
Calm2
|
rno:24244
|
1
|
|
rno04621
|
NOD-like receptor signaling pathway
|
2/344
|
152/7214
|
0.9951788
|
0.9987846
|
ENSRNOG00000007946/ENSRNOG00000007728
|
Bcl2l1/Gsdmd
|
rno:24888/rno:315084
|
2
|
|
rno04080
|
Neuroactive ligand-receptor interaction
|
1/344
|
202/7214
|
0.9999552
|
0.9999552
|
ENSRNOG00000004094
|
Ptger1
|
rno:25637
|
1
|